Clinical Trials

• G-CSF and AMD3100 to Mobilize Stem Cells in Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00082329 - Recruiting
  Healthy
  
• G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00554463 - Not yet recruiting
  Lung Cancer
  
• G-CSF for Granulocyte Donation
  ClinicalTrials.gov Identifier: NCT00001842 - Completed
  Healthy
  
• G-CSF in Preventing Neutropenia During First-Line Treatment With Chemotherapy and Bevacizumab in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00541125 - Not yet recruiting
  Colorectal Cancer
  
• G-CSF in Stimulating Peripheral Stem Cells for Autologous Stem Cell Transplant in Treating Patients With Chronic Phase Chronic Myeloid Leukemia in Complete Remission
  ClinicalTrials.gov Identifier: NCT00233961 - Recruiting
  Leukemia
  
• G-CSF PMRD: Granulocyte Colony Stimulating Factor (G-CSF) Stimulated Bone Marrow and In Vivo T-Cell Depletion in Patients With Hematologic Malignancies or Bone Marrow Failure Syndrome
  ClinicalTrials.gov Identifier: NCT00228813 - Recruiting
  Hematologic Malignancies
  
• G-CSF to Treat Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00025805 - Recruiting
  Crohn's Disease
  
• G-CSF Treatment for Amyotrophic Lateral Sclerosis: A RCT Study Assessing Clinical Response
  ClinicalTrials.gov Identifier: NCT00397423 - Completed
  Amyotrophic Lateral Sclerosis
  
• G-CSF Versus G-CSF Plus GM-CSF for Stem Cell Mobilization in NHL Patients
  ClinicalTrials.gov Identifier: NCT00499343 - Active, not recruiting
  Lymphoma
  
• G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders
  ClinicalTrials.gov Identifier: NCT00253552 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases; Sarcoma
  
• G-PLUS (GALLANT, GALLEX and ARMOR - Post Treatment Follow-up Study)
  ClinicalTrials.gov Identifier: NCT00255645 - Completed
  Type 2 Diabetes
  
• G-Step: Gemcitabine Based Small-Cell Lung Cancer Treatment in Elderly Patients
  ClinicalTrials.gov Identifier: NCT00401609 - Active, not recruiting
  Small Cell Lung Cancer
  
• G207 Followed by Radiation Therapy in Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00157703 - Recruiting
  recurrent/progressive malignant glioma
  
• G3139 and Irinotecan in Treating Patients With Metastatic or Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00004870 - Completed
  recurrent colon cancer; adenocarcinoma of the rectum; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer; ...
  
• Ga68-DOTA-NOC-PET Imaging of Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00569738 - Not yet recruiting
  Neuroendocrine Tumor
  
• GABA Levels in the Brains of Blind People
  ClinicalTrials.gov Identifier: NCT00357409 - Recruiting
  Vision; Blind
  
• GABA Medications for Cocaine Addiction - 3
  ClinicalTrials.gov Identifier: NCT00142883 - Terminated
  
  
• GABA-A alpha2/3 Study
  ClinicalTrials.gov Identifier: NCT00129441 - Active, not recruiting
  Schizophrenia
  
• Gabapentin - A Solution to Uremic Pruritus?
  ClinicalTrials.gov Identifier: NCT00577967 - Not yet recruiting
  Pruritus; Uremia
  
• Gabapentin for Carpal Tunnel Syndrome
  ClinicalTrials.gov Identifier: NCT00137735 - Completed
  Carpal Tunnel Syndrome
  
• Gabapentin for Postoperative Pain Management After Cardiac Surgery With Median Sternotomy
  ClinicalTrials.gov Identifier: NCT00572208 - Not yet recruiting
  Pain, Postoperative
  
• Gabapentin for Smoking Cessation
  ClinicalTrials.gov Identifier: NCT00578552 - Recruiting
  Cigarette Smoking; Tobacco Use
  
• Gabapentin For the Control of Hot Flashes in Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00022074 - Active, not recruiting
  Anxiety Disorder; Breast Cancer; Depression; Hot Flashes; Quality of Life
  
• Gabapentin for the Treatment of Hot Flashes in Menopausal Women
  ClinicalTrials.gov Identifier: NCT00112138 - Active, not recruiting
  Hot Flashes; Menopause
  
• Gabapentin for the Treatment of Neuroleptic-Induced Tremor
  ClinicalTrials.gov Identifier: NCT00533455 - Terminated
  Neuroleptic-Induced Tremor
  
• Gabapentin for the Treatment of Tinnitus
  ClinicalTrials.gov Identifier: NCT00317850 - Terminated
  Tinnitus
  
• Gabapentin in Fibromyalgia Trial (GIFT)
  ClinicalTrials.gov Identifier: NCT00057278 - Completed
  Fibromyalgia
  
• Gabapentin in Phantom and Stump Pain
  ClinicalTrials.gov Identifier: NCT00169013 - Completed
  Amputation of Lower Limb
  
• Gabapentin in Treating Hot Flashes in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00028574 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer; Hot Flashes
  
• Gabapentin in Treating Peripheral Neuropathy in Cancer Patients Undergoing Chemotherapy
  ClinicalTrials.gov Identifier: NCT00027963 - Active, not recruiting
  neurotoxicity; Pain; Quality of Life
  
• Gabapentin to Treat Itch in Patients with Liver Disease
  ClinicalTrials.gov Identifier: NCT00058890 - Completed
  Liver Disease; Cholestasis; Cirrhosis; Pruritus; Itching
  
• Gabapentin Treatment of Alcohol Dependence
  ClinicalTrials.gov Identifier: NCT00391716 - Recruiting
  Alcoholism; Alcohol Abuse; Alcohol Dependence
  
• Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients
  ClinicalTrials.gov Identifier: NCT00420771 - Recruiting
  Benzodiazepine Dependence; Methadone Maintainance
  
• Gabapentin Treatment of Cannabis Dependence
  ClinicalTrials.gov Identifier: NCT00395044 - Recruiting
  Cannabis Dependence
  
• Gabapentin Versus Estrogen for the Treatment of Hot Flashes
  ClinicalTrials.gov Identifier: NCT00276081 - Completed
  Hot Flashes
  
• Gabapentin With or Without Antidepressants in Treating Hot Flashes in Women Who Have Had Breast Cancer or Have Concerns About Taking Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00087399 - Completed
  Breast Cancer; Hot Flashes
  
• Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00006452 - Active, not recruiting
  adult glioblastoma multiforme
  
• Gadolinium Texaphyrin With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas
  ClinicalTrials.gov Identifier: NCT00003410 - Completed
  adult glioblastoma multiforme
  
• Gait Adaptations to Passive Dynamic Akle-Foot Orthosis Use
  ClinicalTrials.gov Identifier: NCT00115401 - Completed
  
  
• Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer Acetate
  ClinicalTrials.gov Identifier: NCT00331747 - Recruiting
  Multiple Sclerosis
  
• Gait Evaluation of Experienced Below Knee Amputees
  ClinicalTrials.gov Identifier: NCT00353626 - Recruiting
  Amputations, Traumatic
  
• Gait Trainer Vs Traditional Physiotherapy in Acute Stroke
  ClinicalTrials.gov Identifier: NCT00307762 - Completed
  Patients With Acute Stroke
  
• Gait Training and Brain Changes in Stroke Patients
  ClinicalTrials.gov Identifier: NCT00334230 - Recruiting
  Gait Training; Locomotion
  
• Gait Training For Acute Stroke: Functional Neuromuscular Stimulation (FNS) and Weight Supported Treadmill Training
  ClinicalTrials.gov Identifier: NCT00101543 - Recruiting
  Stroke
  
• Galantamine Augmentation of Escitalopram for Treatment of Depression
  ClinicalTrials.gov Identifier: NCT00423969 - Terminated
  Depression
  
• Galantamine Executive Function in Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00211588 - Active, not recruiting
  Parkinson's Disease
  
• Galantamine for Cognition in People With Schizophrenia
  ClinicalTrials.gov Identifier: NCT00320736 - Active, not recruiting
  Schizophrenia; Schizoaffective Disorder
  
• Galantamine for Cognitive Deficits in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00463879 - Completed
  Schizophrenia
  
• Galantamine in the Treatment of Post-Traumatic Headache
  ClinicalTrials.gov Identifier: NCT00219869 - Recruiting
  Post-Traumatic Headache; Head Trauma,Closed; Retention Disorders,Cognitive
  
• Galantamine Versus Placebo in Childhood Autism
  ClinicalTrials.gov Identifier: NCT00252603 - Completed
  Autism; Childhood Autism
  
• Galantamine-CR and Cognitive Dysfunction in Bipolar Disorder
  ClinicalTrials.gov Identifier: NCT00181636 - Completed
  Bipolar Disorder
  
• Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00516217 - Not yet recruiting
  Lymphoma
  
• GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate
  ClinicalTrials.gov Identifier: NCT00261352 - Completed
  Type 2 Diabetes
  
• GALLANT 2 Tesaglitazar vs. Placebo
  ClinicalTrials.gov Identifier: NCT00252772 - Completed
  Type 2 Diabetes
  
• GALLANT 22 Tesaglitazar vs. Placebo
  ClinicalTrials.gov Identifier: NCT00252837 - Completed
  Type 2 Diabetes
  
• GALLANT 4 Tesaglitazar vs. Glibenclamide
  ClinicalTrials.gov Identifier: NCT00255541 - Completed
  Type 2 Diabetes
  
• GALLANT 5 Tesaglitazar Versus Metformin
  ClinicalTrials.gov Identifier: NCT00214591 - Completed
  Diabetes Mellitus, Type 2
  
• GALLANT 6 Tesaglitazar Vs. Pioglitazone
  ClinicalTrials.gov Identifier: NCT00214565 - Completed
  Diabetes Mellitus, Type 2
  
• GALLANT 7 Tesaglitazar Add-on to Sulphonylurea
  ClinicalTrials.gov Identifier: NCT00251940 - Completed
  Type 2 Diabetes
  
• GALLANT 8 Tesaglitazar Add-on to Metformin
  ClinicalTrials.gov Identifier: NCT00251953 - Completed
  Type 2 Diabetes
  
• GALLANT 9 Tesaglitazar Vs. Placebo in Combination With Insulin
  ClinicalTrials.gov Identifier: NCT00242372 - Completed
  Type 2 Diabetes Mellitus
  
• Gallbladder Cholesterolosis, Body Mass Index and Serum Cholesterol and Triglycerides
  ClinicalTrials.gov Identifier: NCT00528632 - Not yet recruiting
  Gallstones; Gallbladder Cholesterolosis; Serum Cholesterol and Triglycerides; Body Mass Index
  
• GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00252876 - Completed
  Type 2 Diabetes
  
• GALLEX 4 - Long-Term Extension Study to Evaluate Tesaglitazar Therapy in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00300105 - Completed
  Type 2 Diabetes
  
• GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00226330 - Completed
  Diabetes Mellitus, Type 2
  
• GALLEX 9: Safety and Tolerability of Oral Tesaglitazar When Added to Insulin Therapy in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00229710 - Completed
  Diabetes Mellitus, Type 2
  
• Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00002543 - Completed
  recurrent childhood rhabdomyosarcoma; recurrent neuroblastoma; recurrent childhood large cell lymphoma; ...
  
• Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002578 - Completed
  AIDS-related diffuse small cleaved cell lymphoma; AIDS-related small noncleaved cell lymphoma; AIDS-related lymphoblastic lymphoma; ...
  
• Gamma Interferon Therapy for Chronic Hepatitis C
  ClinicalTrials.gov Identifier: NCT00028275 - Completed
  Chronic Hepatitis C
  
• Gamma Vacuum Foil (GVF) Versus Cross-Linked Polyethylene in Total Knee Arthroplasty Study
  ClinicalTrials.gov Identifier: NCT00289133 - Active, not recruiting
  Osteoarthritis, Knee; Arthritis, Rheumatoid
  
• Ganciclovir by Infusion and by Mouth in Treating Patients With Cytomegalovirus After Donor Bone Marrow Transplant
  ClinicalTrials.gov Identifier: NCT00530218 - Active, not recruiting
  Chronic Myeloproliferative Disorders; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Diseases
  
• Ganciclovir Implant Study for Cytomegalovirus Retinitis
  ClinicalTrials.gov Identifier: NCT00000118 - Completed
  HIV Infections; Acquired Immunodeficiency Syndrome; Cytomegalovirus Retinitis
  
• Ganciclovir Pharmacokinetics in Patients Undergoing Continuous Renal Replacement Therapy
  ClinicalTrials.gov Identifier: NCT00264368 - Terminated
  Acute Renal Failure; Cytomegalovirus Infections; Multi Organ Failure
  
• Ganciclovir Plus Arginine Butyrate in Treating Patients With Cancer or Lymphoproliferative Disorders Associated with the Epstein Barr Virus
  ClinicalTrials.gov Identifier: NCT00006340 - Completed
  Cancer; grade I lymphomatoid granulomatosis; grade II lymphomatoid granulomatosis; recurrent grade I lymphomatoid granulomatosis; ...
  
• Ganciclovir: Compassionate Use in Patients With Serious or Life-Threatening Cytomegalovirus Infections
  ClinicalTrials.gov Identifier: NCT00002024 - Completed
  Cytomegalovirus Infections; HIV Infections
  
• Gardasil (V501) Study in Adult Women
  ClinicalTrials.gov Identifier: NCT00378560 - Active, not recruiting
  Papillomavirus Infections
  
• Gardasil Vaccination as Therapy in Low Grade Cervical Abnormalities
  ClinicalTrials.gov Identifier: NCT00501189 - Recruiting
  Papillomavirus Infections
  
• GARFT Inhibitor in Patients with Metastatic Non-Small Cell Lung Cancer who Failed Two or Three Prior Systemic Treatments
  ClinicalTrials.gov Identifier: NCT00090701 - Completed
  Metastatic Non-Small Cell Lung Cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Garlic in Hyperlipidemia Caused by HAART
  ClinicalTrials.gov Identifier: NCT00029250 - Terminated
  HIV Infections; Hypercholesterolemia; Hypertriglyceridemia; Hyperglycemia
  
• Garlic in Patients With Febrile Neutropenia
  ClinicalTrials.gov Identifier: NCT00247039 - Recruiting
  Post Chemotherapy Induced Febrile Neutropenia
  
• GAS Epi Study to Measure Age-Related Antibody Titers to J8 Vaccine
  ClinicalTrials.gov Identifier: NCT00264784 - Completed
  Streptococcus Group A
  
• Gas Kinetics and Metabolism in Anesthesia During Non Steady State
  ClinicalTrials.gov Identifier: NCT00225381 - Recruiting
  Anesthetized Healthy Patients(ASA 1 or 2) in the Supine Position, Excluding Head, Neck and Head Surgeries; Anesthestized Patient With Severe Systemic Disease (ASA 3 or 4)
  
• Gas Supply, Demand and Middle Ear Gas Balance: Sp Aim 3a Pt ii
  ClinicalTrials.gov Identifier: NCT00494364 - Recruiting
  Healthy
  
• Gas Supply, Demand and Middle Ear Gas Balance: Specific Aim 3c
  ClinicalTrials.gov Identifier: NCT00422851 - Recruiting
  Healthy
  
• Gas Usage for Those With COPD Who Experience Low Oxygen Levels During Activities Only
  ClinicalTrials.gov Identifier: NCT00546299 - Completed
  Chronic Obstructive Pulmonary Disease
  
• Gases Humidification During Noninvasive Ventilation : Heat and Moisture Exchanger or Heated Humidifier ?
  ClinicalTrials.gov Identifier: NCT00221819 - Terminated
  Acute Lung Injury; Pneumonia; Chronic Obstructive Pulmonary Disease; Acute Heart Failure
  
• Gastrectomy Study
  ClinicalTrials.gov Identifier: NCT00160186 - Terminated
  Gastrectomy
  
• Gastric Motor Function Measurement in Dyspepsia and Normal Subjects
  ClinicalTrials.gov Identifier: NCT00296582 - Completed
  Dyspepsia
  
• Gastric Pacemaker Implantation for Gastroparesis
  ClinicalTrials.gov Identifier: NCT00568373 - Recruiting
  Gastroparesis
  
• Gastrodin Prevents Cognitive Decline Related to Cardiopulmonary Bypass
  ClinicalTrials.gov Identifier: NCT00297245 - Recruiting
  Cognitive Decline
  
• Gastrointestinal and Health-Related Quality of Life in Kidney Transplant Patients Treated With Mycophenolate Mofetil
  ClinicalTrials.gov Identifier: NCT00400647 - Recruiting
  Maintenance Kidney Transplant
  
• Gastrointestinal and Health-Related Quality of Life Outcomes in Patients With Autoimmune Diseases Treated With Mycophenolate
  ClinicalTrials.gov Identifier: NCT00351377 - Recruiting
  Autoimmune Disease
  
• Gastrointestinal and Health-Related Quality of Life Outcomes in Patients With Simultaneous Pancreas-Kidney Transplants
  ClinicalTrials.gov Identifier: NCT00267150 - Recruiting
  Pancreas Transplantation; Kidney Transplantation
  
• Gastrointestinal Evaluation in Young Men With Iron Deficiency Anemia
  ClinicalTrials.gov Identifier: NCT00498511 - Not yet recruiting
  Anemia, Iron-Deficiency
  
• Gastrointestinal Stromal Tumors Registry
  ClinicalTrials.gov Identifier: NCT00507273 - Recruiting
  Gastrointestinal Stromal Tumors
  
• Gastrointestinal Ulceration in Patients on Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
  ClinicalTrials.gov Identifier: NCT00413309 - Active, not recruiting
  Acute Coronary Syndrome
  
• Gastroparesis Registry
  ClinicalTrials.gov Identifier: NCT00398801 - Recruiting
  Gastroparesis
  
• Gatekeeper European 005
  ClinicalTrials.gov Identifier: NCT00229086 - Terminated
  GERD
  
• GB/MF59 Vaccine in Preventing CMV Infection in Healthy Adolescent Females
  ClinicalTrials.gov Identifier: NCT00133497 - Recruiting
  Cytomegalovirus Infections
  
• GBR 12909 Study in Cocaine Experienced African American Volunteers - 1
  ClinicalTrials.gov Identifier: NCT00089687 - Active, not recruiting
  Cocaine-Related Disorders
  
• GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma
  ClinicalTrials.gov Identifier: NCT00112099 - Recruiting
  Gastric Neoplasm
  
• GECO: Study of Rofecoxib and Prolonged Constant Infusion of Gemcitabine in the Polychemotherapy Treatment of Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00385606 - Completed
  Advanced Non-Small Cell Lung Cancer
  
• Gefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck Cancer
  ClinicalTrials.gov Identifier: NCT00239304 - Completed
  Head and Neck Neoplasms
  
• Gefitinib After Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00091156 - Recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00068653 - Active, not recruiting
  recurrent non-small cell lung cancer
  
• Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00052585 - Completed
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
  
• Gefitinib and Combination Chemotherapy in Treating Patients With Advanced Solid Tumors or Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00025142 - Active, not recruiting
  stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
  
• Gefitinib and Docetaxel in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00084786 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Gefitinib and Etoposide in Treating Patients With Advanced Prostate Cancer That Did Not Respond to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00483561 - Recruiting
  Prostate Cancer
  
• Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00096486 - Recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer
  ClinicalTrials.gov Identifier: NCT00423397 - Recruiting
  Non-Melanomatous Skin Cancer
  
• Gefitinib and PEG-Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00467077 - Recruiting
  Kidney Cancer
  
• Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
  ClinicalTrials.gov Identifier: NCT00042991 - Active, not recruiting
  untreated childhood brain stem glioma
  
• Gefitinib and Radiation Therapy in Treating Patients With Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00052208 - Active, not recruiting
  adult glioblastoma multiforme
  
• Gefitinib and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00033449 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00098462 - Recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Gefitinib as First-Line Therapy Followed by Gemcitabine and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00217698 - Active, not recruiting
  Lung Cancer
  
• Gefitinib Followed By Surgery in Treating Women With Ductal Carcinoma In Situ of the Breast
  ClinicalTrials.gov Identifier: NCT00082667 - Active, not recruiting
  breast cancer in situ; intraductal breast carcinoma
  
• Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer
  ClinicalTrials.gov Identifier: NCT00237900 - Terminated
  Subjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GC
  
• Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy
  ClinicalTrials.gov Identifier: NCT00241475 - Completed
  Prostate Cancer
  
• Gefitinib in Treating Children With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00040781 - Completed
  unspecified childhood solid tumor, protocol specific
  
• Gefitinib in Treating Patients Who Are Undergoing Surgery and/or Radiation Therapy for Locally Advanced or Recurrent Squamous Cell Skin Cancer
  ClinicalTrials.gov Identifier: NCT00126555 - Recruiting
  squamous cell carcinoma of the skin; recurrent skin cancer
  
• Gefitinib in Treating Patients Who Are Undergoing Surgery for Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00104728 - Recruiting
  stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer
  
• Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
  ClinicalTrials.gov Identifier: NCT00071994 - Active, not recruiting
  advanced adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma; ...
  
• Gefitinib in Treating Patients With Cervical Cancer
  ClinicalTrials.gov Identifier: NCT00049556 - Completed
  Cervical Cancer; Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer
  ClinicalTrials.gov Identifier: NCT00100945 - Active, not recruiting
  Adenocarcinoma of the Esophagus; stage II esophageal cancer
  
• Gefitinib in Treating Patients With Locally Advanced or Metastatic Synovial Sarcoma
  ClinicalTrials.gov Identifier: NCT00052754 - Active, not recruiting
  adult synovial sarcoma; stage III adult soft tissue sarcoma; recurrent adult soft tissue sarcoma; stage IV adult soft tissue sarcoma
  
• Gefitinib in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer That Did Not Respond to Iodine Therapy
  ClinicalTrials.gov Identifier: NCT00095836 - Active, not recruiting
  anaplastic thyroid cancer; follicular thyroid cancer; medullary thyroid cancer; papillary thyroid cancer; Thyroid Cancer
  
• Gefitinib in Treating Patients With Metastatic Breast Cancer That Has Progressed After Antiestrogen and Nonsteroidal Aromatase Inhibitor Therapy
  ClinicalTrials.gov Identifier: NCT00066339 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00068497 - Active, not recruiting
  Head and Neck Cancer; thorax and respiratory cancer
  
• Gefitinib in Treating Patients With Non-Small Cell Lung Cancer That Has Been Surgically Removed
  ClinicalTrials.gov Identifier: NCT00049543 - Active, not recruiting
  Non-small cell lung cancer
  
• Gefitinib in Treating Patients With Persistent or Recurrent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00027690 - Active, not recruiting
  recurrent endometrial cancer
  
• Gefitinib in Treating Patients With Previously Untreated Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00411047 - Active, not recruiting
  Lung Cancer
  
• Gefitinib in Treating Patients With Progressive Metastatic Neuroendocrine Tumors
  ClinicalTrials.gov Identifier: NCT00075439 - Active, not recruiting
  Gastrinoma; gastrointestinal carcinoid tumor; Insulinoma; Islet Cell Carcinoma; metastatic gastrointestinal carcinoid tumor; ...
  
• Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00024089 - Active, not recruiting
  Head and Neck Cancer
  
• Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer
  ClinicalTrials.gov Identifier: NCT00268346 - Recruiting
  Esophageal Cancer
  
• Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors
  ClinicalTrials.gov Identifier: NCT00025675 - Active, not recruiting
  adult brain tumor
  
• Gefitinib in Treating Patients With Stage I, Stage II, or Stage III Esophageal Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00258297 - Recruiting
  Esophageal Cancer
  
• Gefitinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00029003 - Active, not recruiting
  recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; Bronchoalveolar Cell Lung Cancer
  
• Gefitinib Plus Combination Chemotherapy in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00041106 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma
  ClinicalTrials.gov Identifier: NCT00027625 - Completed
  recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; adult anaplastic oligodendroglioma; Mixed Gliomas
  
• Gefitinib With or Without Carboplatin and Paclitaxel in Treating Older Patients With Unresectable or Metastatic Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00062062 - Active, not recruiting
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Gefitinib With or Without Fulvestrant in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00100854 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Gefitinib With or Without Simvastatin in NSCLC
  ClinicalTrials.gov Identifier: NCT00452244 - Recruiting
  Lung Cancer
  
• Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00080743 - Active, not recruiting
  recurrent breast cancer; stage IV breast cancer
  
• Gefitinib, Capecitabine, and Celecoxib in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00039390 - Completed
  unspecified adult solid tumor, protocol specific
  
• Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00290719 - Recruiting
  Esophageal Cancer
  
• Gefitinib, Docetaxel, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00310154 - Active, not recruiting
  Lung Cancer
  
• Gefitinib, Paclitaxel, and Radiation Therapy in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00083057 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Nasopharyngeal Cancer; Oropharyngeal Cancer; ...
  
• Gefitinib, Trastuzumab, and Docetaxel in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00086957 - Recruiting
  stage IV breast cancer; Male Breast Cancer; recurrent breast cancer
  
• Gel-200 Extension and Open-Label Study in Osteoarthritis of the Knee
  ClinicalTrials.gov Identifier: NCT00450112 - Recruiting
  Osteoarthritis of the Knee
  
• Gel-200 Versus Placebo in Osteoarthritis of the Knee
  ClinicalTrials.gov Identifier: NCT00449696 - Active, not recruiting
  Osteoarthritis of the Knee
  
• Geldanamycin Analogue in Treating Patients With Advanced Cancer
  ClinicalTrials.gov Identifier: NCT00003969 - Completed
  unspecified adult solid tumor, protocol specific
  
• Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00019708 - Recruiting
  Lymphoma; Unspecified Adult Solid Tumor, Protocol Specific
  
• GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD
  ClinicalTrials.gov Identifier: NCT00546624 - Completed
  Anxiety Disorder
  
• GEM OS™1 Bone Graft Compared to Autologous Bone Graft in Foot and Ankle Fusions
  ClinicalTrials.gov Identifier: NCT00583375 - Recruiting
  Fusion
  
• GEM vs GEM+TS-1 for Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00514163 - Recruiting
  Pancreatic Cancer
  
• GEM05 for Patients With Multiple Myeloma More Than 65 Years Old
  ClinicalTrials.gov Identifier: NCT00443235 - Recruiting
  Multiple Myeloma
  
• GEM05 for Patients With Multiple Myeloma Under 65 Years
  ClinicalTrials.gov Identifier: NCT00461747 - Recruiting
  Multiple Myeloma
  
• Gemcitabine (GEMZAR) Plus ABI-007 (ABRAXANE)In Patients With Advanced Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00398086 - Recruiting
  Advanced Metastatic Pancreatic Cancer
  
• Gemcitabine + Carboplatin in Breast Cancer
  ClinicalTrials.gov Identifier: NCT00450762 - Completed
  Breast Cancer
  
• Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00445601 - Recruiting
  Bladder Cancer
  
• Gemcitabine Alone or in Combination With Other Chemotherapy Drugs in Treating Patients With Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00012220 - Active, not recruiting
  adenocarcinoma of the pancreas; stage IVB pancreatic cancer
  
• Gemcitabine and Bevacizumab in Treating Patients With Pancreatic Cancer That Has Been Completely Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00410774 - Recruiting
  Pancreatic Cancer
  
• Gemcitabine and Bortezomib in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00290706 - Suspended
  Lymphoma
  
• Gemcitabine and Capecitabine in Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00316420 - Recruiting
  Pancreatic Cancer
  
• Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder
  ClinicalTrials.gov Identifier: NCT00084942 - Active, not recruiting
  cholangiocarcinoma of the gallbladder; recurrent gallbladder cancer; unresectable gallbladder cancer; ...
  
• Gemcitabine and Capecitabine in Treating Patients With Advanced Renal Cell (Kidney) Cancer
  ClinicalTrials.gov Identifier: NCT00058318 - Active, not recruiting
  Stage IV Renal Cell Cancer; stage III renal cell cancer
  
• Gemcitabine and Capecitabine in Treating Patients With Unresectable Locally Advanced or Metastatic Gallbladder Cancer or Cholangiocarcinoma
  ClinicalTrials.gov Identifier: NCT00033540 - Active, not recruiting
  extrahepatic bile duct cancer; Gallbladder Cancer
  
• Gemcitabine and Capecitabine With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00425360 - Recruiting
  Pancreatic Cancer
  
• Gemcitabine and Carboplatin Followed By Docetaxel in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00074204 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Gemcitabine and Carboplatin Followed by Paclitaxel in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00276588 - Active, not recruiting
  Lung Cancer
  
• Gemcitabine and Carboplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer That Responded to Previous Cisplatin or Carboplatin
  ClinicalTrials.gov Identifier: NCT00369954 - Not yet recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00326599 - Suspended
  Lung Cancer
  
• Gemcitabine and Celecoxib in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00068432 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Gemcitabine and Cisplatin Before or After Surgery in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00398385 - Recruiting
  Lung Cancer
  
• Gemcitabine and Cisplatin for Advanced or Recurrent Endometrial Cancer
  ClinicalTrials.gov Identifier: NCT00388154 - Recruiting
  Endometrial Cancer
  
• Gemcitabine and Cisplatin for Gallbladder and Biliary Tract Cancer
  ClinicalTrials.gov Identifier: NCT00123825 - Completed
  Gallbladder Cancer; Biliary Tract Cancer
  
• Gemcitabine and Cisplatin in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00002998 - Completed
  stage IV breast cancer; recurrent breast cancer
  
• Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors
  ClinicalTrials.gov Identifier: NCT00004090 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00006482 - Completed
  recurrent cervical cancer; cervical squamous cell carcinoma; stage IVA cervical cancer; stage IVB cervical cancer
  
• Gemcitabine and Dasatinib in Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00429234 - Recruiting
  Advanced Cancer; Solid Tumors
  
• Gemcitabine and Docetaxel in Treating Patients With Inoperable Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00075517 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; Adenocarcinoma of the Lung; large cell lung cancer; ...
  
• Gemcitabine and Docetaxel in Treating Patients With Metastatic Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00276549 - Active, not recruiting
  Prostate Cancer
  
• Gemcitabine and Docetaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00248560 - Recruiting
  Head and Neck Cancer
  
• Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer
  ClinicalTrials.gov Identifier: NCT00114218 - Suspended
  uterine carcinosarcoma; recurrent uterine sarcoma
  
• Gemcitabine and Docetaxel in Treating Patients With Recurrent Osteosarcoma or Ewing's Sarcoma or Unresectable or Locally Recurrent Chondrosarcoma
  ClinicalTrials.gov Identifier: NCT00073983 - Recruiting
  recurrent tumors of the Ewing's family; Chondrosarcoma; recurrent osteosarcoma
  
• Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00278460 - Completed
  Lung Cancer
  
• Gemcitabine and Docetaxel in Treating Patients With Relapsed or Refractory Ovarian Epithelial or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00227721 - Recruiting
  Ovarian Cancer; Peritoneal Cavity Cancer
  
• Gemcitabine and Docetaxel to Treat Bone and Soft Tissue Cancers
  ClinicalTrials.gov Identifier: NCT00070772 - Recruiting
  Osteosarcoma; Sarcoma, Ewing's; Chondrosarcoma
  
• Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00509665 - Recruiting
  Head and Neck Cancer
  
• Gemcitabine and Epirubicin in Treating Patients With Malignant Mesothelioma
  ClinicalTrials.gov Identifier: NCT00017186 - Active, not recruiting
  localized malignant mesothelioma; advanced malignant mesothelioma; recurrent malignant mesothelioma
  
• Gemcitabine and Flavopiridol in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00072436 - Recruiting
  unspecified adult solid tumor, protocol specific
  
• Gemcitabine and Hodgkin's Disease Chemotherapy Followed by Peripheral Blood Stem Cell Rescue for Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00388349 - Recruiting
  Hodgkin's Disease; Lymphoma
  
• Gemcitabine and Ifosfamide As a Second-Line Systemic Chemotherapy for Cisplatin -Failed Advanced TCC
  ClinicalTrials.gov Identifier: NCT00173862 - Completed
  Transitional Cell Carcinoma
  
• Gemcitabine and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00323362 - Recruiting
  Lung Cancer
  
• Gemcitabine and Irinotecan in Treating Patients With Cancer of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00066781 - Active, not recruiting
  adenocarcinoma of unknown primary; newly diagnosed carcinoma of unknown primary; squamous cell carcinoma of unknown primary; ...
  
• Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00089128 - Active, not recruiting
  transitional cell carcinoma of the bladder; recurrent bladder cancer; stage III bladder cancer; stage IV bladder cancer
  
• Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00089102 - Active, not recruiting
  recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
  
• Gemcitabine and Irinotecan in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00401128 - Completed
  Kidney Cancer
  
• Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus
  ClinicalTrials.gov Identifier: NCT00012363 - Active, not recruiting
  stage IV gastric cancer; recurrent gastric cancer; stage IV esophageal cancer; recurrent esophageal cancer; adenocarcinoma of the stomach; ...
  
• Gemcitabine and ISIS 2503 in Treating Patients With Advanced or Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00006467 - Completed
  recurrent pancreatic cancer; stage IVA pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage III pancreatic cancer; ...
  
• Gemcitabine and Liposomal Doxorubicin in Treating Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005991 - Completed
  stage IV breast cancer; recurrent breast cancer
  
• Gemcitabine and Mitoxantrone in Treating Patients With Relapsed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00268242 - Recruiting
  Adult Acute Erythroid Leukemia; Adult Acute Monoblastic and Acute Monocytic Leukemia; Adult Acute Myeloid Leukemia
  
• Gemcitabine and Monoclonal Antibody Therapy in Treating Patients With Metastatic Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00003797 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Gemcitabine and Oxaliplatin (GEMOX) in First Line Metastatic or Recurrent Nasopharyngeal Carcinoma
  ClinicalTrials.gov Identifier: NCT00436800 - Active, not recruiting
  Nasopharyngeal Neoplasms
  
• Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer
  ClinicalTrials.gov Identifier: NCT00276861 - Active, not recruiting
  Colorectal Cancer
  
• Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00305786 - Recruiting
  Lung Cancer
  
• Gemcitabine and Oxaliplatin Followed By Radiation Therapy, Fluorouracil, and Oxaliplatin in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00275119 - Active, not recruiting
  Pancreatic Cancer
  
• Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter
  ClinicalTrials.gov Identifier: NCT00250822 - Active, not recruiting
  Liver Cancer
  
• Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00006117 - Active, not recruiting
  stage III pancreatic cancer; stage IV pancreatic cancer; adenocarcinoma of the pancreas
  
• Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Cancer
  ClinicalTrials.gov Identifier: NCT00274859 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Gemcitabine and Oxaliplatin in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00268411 - Active, not recruiting
  Pancreatic Cancer
  
• Gemcitabine and Oxaliplatin in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00536874 - Recruiting
  Pancreatic Cancer
  
• Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract
  ClinicalTrials.gov Identifier: NCT00022633 - Active, not recruiting
  Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
  
• Gemcitabine and Paclitaxel in Treating Patients With Persistent, Recurrent, or Metastatic Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00100789 - Active, not recruiting
  Head and Neck Cancer
  
• Gemcitabine and Pemetrexed Disodium in Treating Patients With Advanced Mycosis Fungoides or Sézary Syndrome
  ClinicalTrials.gov Identifier: NCT00369629 - Recruiting
  Lymphoma
  
• Gemcitabine and Pemetrexed in Primary Unknown Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00191503 - Completed
  Adenocarcinoma
  
• Gemcitabine and Radiation Therapy Compared With Gemcitabine Alone in Treating Patients Who Have Undergone Surgery for Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00064207 - Active, not recruiting
  adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer
  
• Gemcitabine and Radiation Therapy in Treating Patients With Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00010166 - Completed
  stage I pancreatic cancer; adenocarcinoma of the pancreas
  
• Gemcitabine and Radiation Therapy in Treating Patients With Locally Advanced Upper Gastrointestinal Cancer
  ClinicalTrials.gov Identifier: NCT00544193 - Active, not recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer; Gastric Cancer; Pancreatic Cancer; Small Intestine Cancer
  
• Gemcitabine and Tanespimycin in Treating Patients With Stage IV Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00577889 - Not yet recruiting
  Pancreatic Cancer
  
• Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer
  ClinicalTrials.gov Identifier: NCT00217555 - Active, not recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• Gemcitabine and Vinorelbine in Treating Young Patients With Recurrent or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00070304 - Active, not recruiting
  recurrent/refractory childhood Hodgkin's lymphoma; childhood lymphocyte predominant Hodgkin's lymphoma; ...
  
• Gemcitabine and/or Erlotinib as First-Line Therapy in Treating Older Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00283244 - Recruiting
  Lung Cancer
  
• Gemcitabine Combinations in Metastatic Breast Cancer (MBC), 1st Line
  ClinicalTrials.gov Identifier: NCT00191854 - Recruiting
  Breast Neoplasms
  
• Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00049608 - Active, not recruiting
  Breast Cancer; Colorectal Cancer; Lung Cancer; Pancreatic Cancer
  
• Gemcitabine Compared With Pancreatic Enzyme Therapy Plus Specialized Diet (Gonzalez Regimen) in Treating Patients Who Have Stage II, Stage III, or Stage IV Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003851 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; stage IV pancreatic cancer; Nutrition; adenocarcinoma of the pancreas
  
• Gemcitabine for Marginal Zone Lymphoma
  ClinicalTrials.gov Identifier: NCT00337259 - Recruiting
  Non-Hodgkin's Lymphoma
  
• Gemcitabine Hydrochloride and Genistein in Treating Women With Stage IV Breast Cancer
  ClinicalTrials.gov Identifier: NCT00244933 - Recruiting
  Breast Cancer
  
• Gemcitabine in Combination With Cisplatin as Neoadjuvant NSCLC Chemotherapy
  ClinicalTrials.gov Identifier: NCT00191841 - Completed
  Carcinoma, Non-Small-Cell Lung
  
• Gemcitabine in Combination With Either Cisplatin or Carboplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00112710 - Recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
  
• Gemcitabine in Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00191334 - Active, not recruiting
  Ovarian Cancer
  
• Gemcitabine in Treating Children With Refractory Solid Tumors
  ClinicalTrials.gov Identifier: NCT00005577 - Completed
  unspecified childhood solid tumor, protocol specific
  
• Gemcitabine in Treating Children With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00006462 - Active, not recruiting
  recurrent childhood acute lymphoblastic leukemia; recurrent childhood acute myeloid leukemia
  
• Gemcitabine in Treating Elderly Women With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00005614 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Gemcitabine in Treating Neoplastic Meningitis in Patients With Leukemia, Lymphoma, or Solid Tumors
  ClinicalTrials.gov Identifier: NCT00052806 - Recruiting
  leptomeningeal metastases
  
• Gemcitabine in Treating Patients With Advanced Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00007943 - Completed
  recurrent colon cancer; stage III colon cancer; stage III rectal cancer; Stage IV rectal cancer; recurrent rectal cancer; stage IV colon cancer
  
• Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery
  ClinicalTrials.gov Identifier: NCT00003744 - Active, not recruiting
  high-grade salivary gland carcinoma; low-grade salivary gland carcinoma; Salivary Gland Cancer
  
• Gemcitabine in Treating Patients With Metastatic Cancer of Unknown Primary
  ClinicalTrials.gov Identifier: NCT00357630 - Active, not recruiting
  Carcinoma of Unknown Primary; Pain
  
• Gemcitabine in Treating Patients With Newly Diagnosed, Relapsed, or Chemotherapy-Resistant Mantle Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00234026 - Active, not recruiting
  Lymphoma
  
• Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the Cervix
  ClinicalTrials.gov Identifier: NCT00006224 - Completed
  recurrent cervical cancer; cervical adenocarcinoma; cervical adenosquamous cell carcinoma
  
• Gemcitabine in Treating Patients With Recurrent Bladder Cancer That Has Not Responded to Previous Bacillus Calmette-Guerin
  ClinicalTrials.gov Identifier: NCT00234039 - Recruiting
  Recurrent Bladder Cancer; Stage 0 Bladder Cancer; Stage I Bladder Cancer; Transitional Cell Carcinoma of the Bladder
  
• Gemcitabine in Treating Patients With Recurrent Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00005829 - Active, not recruiting
  refractory chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
  
• Gemcitabine in Treating Patients With Recurrent or Metastatic Adenoid Cystic Cancer of the Head and Neck
  ClinicalTrials.gov Identifier: NCT00017498 - Active, not recruiting
  stage IV salivary gland cancer; recurrent salivary gland cancer; salivary gland adenoid cystic carcinoma; ...
  
• Gemcitabine in Treating Patients With Recurrent or Refractory Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00014287 - Completed
  stage I bladder cancer; stage 0 bladder cancer; recurrent bladder cancer
  
• Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the Uterus
  ClinicalTrials.gov Identifier: NCT00003316 - Completed
  uterine leiomyosarcoma; recurrent uterine sarcoma
  
• Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and Paclitaxel
  ClinicalTrials.gov Identifier: NCT00003540 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer
  
• Gemcitabine Monotherapy for Metastatic Breast Cancer After Anthracycline and Taxane Regimen
  ClinicalTrials.gov Identifier: NCT00191269 - Active, not recruiting
  Metastatic Breast Cancer After Anthracycline, Taxane Regimen
  
• Gemcitabine or Gemcitabine Plus Docetaxel After Cisplatin, Etoposide and Radiation in Non Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00191139 - Active, not recruiting
  Carcinoma, Non Small Cell Lung
  
• Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies
  ClinicalTrials.gov Identifier: NCT00410982 - Recruiting
  Leukemia; Lymphoma; Myeloma
  
• Gemcitabine Plus Carboplatin or Cisplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004201 - Completed
  stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Gemcitabine plus Carboplatin versus Carboplatin Monotherapy in Patients with Advanced Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00102414 - Completed
  Ovarian Cancer
  
• Gemcitabine Plus Cisplatin in Treating Patients With Malignant Mesothelioma of the Pleura That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00003723 - Active, not recruiting
  advanced malignant mesothelioma; sarcomatous mesothelioma; epithelial mesothelioma
  
• Gemcitabine Plus Cisplatin in Treating Patients With Metastatic Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00003928 - Active, not recruiting
  Stage IV Renal Cell Cancer; recurrent renal cell cancer
  
• Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based Chemotherapy
  ClinicalTrials.gov Identifier: NCT00006028 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer
  
• Gemcitabine Plus Cisplatin Single Dose Versus Split Dose in the Treatment of Patients With Locally Advanced or Metastatic Breast Cancer After Failure of Anthracyclines and/or Taxanes
  ClinicalTrials.gov Identifier: NCT00192101 - Completed
  Metastatic Breast Cancer
  
• Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
  ClinicalTrials.gov Identifier: NCT00006010 - Active, not recruiting
  localized unresectable adult primary liver cancer; advanced adult primary liver cancer; recurrent adult primary liver cancer; ...
  
• Gemcitabine Plus Docetaxel or Irinotecan in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004139 - Active, not recruiting
  stage IV non-small cell lung cancer; Squamous Cell Lung Cancer; Bronchoalveolar Cell Lung Cancer; stage IIIB non-small cell lung cancer; ...
  
• Gemcitabine Plus Erlotinib Versus Erlotinib Plus Gemcitabine Plus Oxaliplatin,in Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00564720 - Recruiting
  Pancreatic Cancer
  
• Gemcitabine Plus Flavopiridol in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00007917 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Gemcitabine Plus High-Dose 5-Fu/Leucovorin in the Treatment of Advanced or Metastatic Carcinoma of the Biliary Tract
  ClinicalTrials.gov Identifier: NCT00201305 - Completed
  Biliary Tract Disease
  
• Gemcitabine Plus Oxaliplatin in Advanced Stage IIIB/IV NSCLC
  ClinicalTrials.gov Identifier: NCT00453115 - Recruiting
  Lung Cancer
  
• Gemcitabine Plus Oxaliplatin in Treating Patients With Refractory Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00004190 - Completed
  recurrent pancreatic cancer; stage IVA pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage III pancreatic cancer; ...
  
• Gemcitabine Plus Paclitaxel in Treating Patients With Advanced Non-small Cell Lung Cancer or Other Solid Tumor
  ClinicalTrials.gov Identifier: NCT00004159 - Completed
  stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00059865 - Active, not recruiting
  advanced adult primary liver cancer; unresectable gallbladder cancer; unresectable extrahepatic bile duct cancer; ...
  
• Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003426 - Completed
  stage II pancreatic cancer; stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Gemcitabine Plus Radiation Therapy in Treating Patients With Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00003546 - Active, not recruiting
  stage III pancreatic cancer; adenocarcinoma of the pancreas; stage I pancreatic cancer; stage II pancreatic cancer
  
• Gemcitabine Plus Radiation Therapy or Combination Chemotherapy in Treating Patients With Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00003202 - Completed
  stage IIIA non-small cell lung cancer; Adenosquamous Cell Lung Cancer; Squamous Cell Lung Cancer; stage IIIB non-small cell lung cancer; ...
  
• Gemcitabine Plus Supportive Care in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00022009 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Gemcitabine With Curcumin for Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00192842 - Recruiting
  Pancreatic Cancer
  
• Gemcitabine With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00088894 - Active, not recruiting
  adenocarcinoma of the pancreas; recurrent pancreatic cancer; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; ...
  
• Gemcitabine With or Without Capecitabine in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00030732 - Active, not recruiting
  stage III pancreatic cancer; recurrent pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Gemcitabine With or Without Capecitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00032175 - Completed
  stage III pancreatic cancer; duct cell adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Gemcitabine With or Without cBR96-Doxorubicin Immunoconjugate (SGN-15) in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00056017 - Suspended
  recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ovarian endometrioid adenocarcinoma; ...
  
• Gemcitabine With or Without Cetuximab as First-Line Therapy in Treating Patients With Locally Advanced Unresectable or Metastatic Adenocarcinoma of the Pancreas
  ClinicalTrials.gov Identifier: NCT00075686 - Active, not recruiting
  adenocarcinoma of the pancreas; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Gemcitabine With or Without CI-994 in Treating Patients With Advanced Non-small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005093 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
  
• Gemcitabine With or Without CI-994 in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00004861 - Active, not recruiting
  stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors
  ClinicalTrials.gov Identifier: NCT00262769 - Recruiting
  Extrahepatic Bile Duct Cancer; Gallbladder Cancer
  
• Gemcitabine With or Without Combination Chemotherapy and Radiation Therapy in Treating Patients With Nonmetastatic Pancreatic Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00416507 - Active, not recruiting
  Pancreatic Cancer
  
• Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00462852 - Recruiting
  Pancreatic Cancer; Thromboembolism
  
• Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00031837 - Active, not recruiting
  adenocarcinoma of the pancreas; Pancreatic Cancer; Quality of Life; Thromboembolism
  
• Gemcitabine With or Without Docetaxel as Second-Line Therapy in Treating Patients With Metastatic or Relapsed, Unresectable Uterine or Soft Tissue Leiomyosarcoma
  ClinicalTrials.gov Identifier: NCT00227669 - Recruiting
  Sarcoma
  
• Gemcitabine With or Without Erlotinib in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00026338 - Active, not recruiting
  stage III pancreatic cancer; adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Gemcitabine With or Without Exatecan Mesylate in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00023972 - Active, not recruiting
  stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00323791 - Completed
  Kidney Cancer
  
• Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Previously Treated Locally Advanced or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00323063 - Recruiting
  Breast Cancer
  
• Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00058149 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Unresectable Pancreatic Adenocarcinoma
  ClinicalTrials.gov Identifier: NCT00075452 - Active, not recruiting
  adenocarcinoma of the pancreas; stage II pancreatic cancer; stage III pancreatic cancer; stage IVA pancreatic cancer; stage IVB pancreatic cancer
  
• Gemcitabine With or Without Pemetrexed Disodium in Treating Patients With Unresectable Stage II, Stage III, or Stage IV Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00049426 - Active, not recruiting
  stage II pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; stage IVA pancreatic cancer; adenocarcinoma of the pancreas
  
• Gemcitabine With or Without R115777 in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00005648 - Active, not recruiting
  recurrent pancreatic cancer; stage II pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; ...
  
• Gemcitabine With or Without Radiation Therapy in Treating Patients with Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00057876 - Active, not recruiting
  stage III pancreatic cancer; adenocarcinoma of the pancreas
  
• Gemcitabine With or Without Sorafenib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00541021 - Recruiting
  Pancreatic Cancer
  
• Gemcitabine With or Without WX-671 in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00499265 - Recruiting
  Pancreatic Cancer
  
• Gemcitabine, 5-Fluorouracil, and Radiation Therapy in the Treatment of Non-Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00251355 - Terminated
  Pancreatic Cancer
  
• Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00366457 - Recruiting
  Pancreatic Cancer; Adenocarcinoma of the Pancreas
  
• Gemcitabine, Bevacizumab, and Abdominal Radiation Therapy in Treating Patients With Localized Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00460174 - Recruiting
  Pancreatic Cancer
  
• Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00100815 - Active, not recruiting
  adenocarcinoma of the pancreas; stage IVA pancreatic cancer; stage IVB pancreatic cancer; recurrent pancreatic cancer
  
• Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00524069 - Recruiting
  Pancreatic Cancer
  
• Gemcitabine, Capecitabine, and Oxaliplatin as Second-Line Therapy in Treating Patients With Advanced Colorectal Cancer Previously Treated With Irinotecan
  ClinicalTrials.gov Identifier: NCT00496704 - Recruiting
  Colorectal Cancer
  
• Gemcitabine, Carboplatin or Paclitaxel Plus Radiation Therapy in Treating Patients With Stage IIIA or IIIB Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00016315 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Gemcitabine, Carboplatin, and Bortezomib in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00075751 - Active, not recruiting
  stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Gemcitabine, Carboplatin, and Dexamethasone With or Without Rituximab in Treating Patients With Relapsed or Primary Refractory Lymphoma
  ClinicalTrials.gov Identifier: NCT00072514 - Completed
  Hodgkin's lymphoma; adult T-cell leukemia and lymphoma; anaplastic large cell lymphoma; angioimmunoblastic T-cell lymphoma; Cutaneous T-Cell Lymphoma; ...
  
• Gemcitabine, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery
  ClinicalTrials.gov Identifier: NCT00467116 - Suspended
  Pancreatic Cancer
  
• Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00006105 - Active, not recruiting
  stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer; Drug Toxicity
  
• Gemcitabine, Cisplatin, and Bevacizumab in Treating Patients With Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00126633 - Active, not recruiting
  stage IVA pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Gemcitabine, Cisplatin, and Celecoxib Treatment of Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00176813 - Active, not recruiting
  Pancreatic Cancer
  
• Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00090909 - Completed
  recurrent adult Hodgkin's lymphoma
  
• Gemcitabine, Cisplatin, and Gefitinib in Treating Patients Who are Undergoing Surgery for Stage III Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00103051 - Active, not recruiting
  stage IIIA non-small cell lung cancer
  
• Gemcitabine, Cisplatin, and Radiation Therapy Followed By Surgery or Surgery Alone in Treating Patients With Localized Pancreatic Cancer That Can Be Removed By Surgery
  ClinicalTrials.gov Identifier: NCT00335543 - Recruiting
  Pancreatic Cancer
  
• Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00556621 - Recruiting
  Bladder Cancer
  
• Gemcitabine, Dexamethasone and Cisplatin Versus Dexamethasone, Cytarabine, Cisplatin in Patients With Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00089817 - Recruiting
  Lymphoma
  
• Gemcitabine, Docetaxel, and Capecitabine in Treating Patients with Cancer of Unknown Primary Origin
  ClinicalTrials.gov Identifier: NCT00119314 - Active, not recruiting
  newly diagnosed carcinoma of unknown primary; recurrent carcinoma of unknown primary
  
• Gemcitabine, Docetaxel, and Cetuximab in Patients With Unresectable Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00193453 - Active, not recruiting
  Lung Cancer
  
• Gemcitabine, Docetaxel, and Filgrastim in Treating Patients With Recurrent or Persistent Leiomyosarcoma or Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00004066 - Active, not recruiting
  adult soft tissue sarcoma; ovarian sarcoma; small intestine cancer; uterine sarcoma
  
• Gemcitabine, Doxorubicin and Paclitaxel (GAT) as Neoadjuvant Treatment of Breast Cancer Patients.
  ClinicalTrials.gov Identifier: NCT00128856 - Completed
  Breast Cancer
  
• Gemcitabine, Herceptin and Radiation to Treat Cancer of the Pancreas
  ClinicalTrials.gov Identifier: NCT00005926 - Completed
  Pancreatic Cancer; Pancreatic Neoplasm
  
• Gemcitabine, Infusional 5 Fluorouracil and Bevacizumab in Patients With Advanced Pancreas Cancer
  ClinicalTrials.gov Identifier: NCT00417976 - Recruiting
  Pancreatic Cancer
  
• Gemcitabine, Oxaliplatin and Capecitabine in Patients With Advanced Cholangiocarcinoma.
  ClinicalTrials.gov Identifier: NCT00350961 - Recruiting
  Cholangiocarcinoma
  
• Gemcitabine, Oxaliplatin and Radiation Therapy in Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00242190 - Active, not recruiting
  Pancreatic Neoplasms
  
• Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00191568 - Completed
  Pancreatic Neoplasms
  
• Gemcitabine, Oxaliplatin in Combination With Bevacizumab in Biliary Tract and Gallbladder Cancer
  ClinicalTrials.gov Identifier: NCT00361231 - Recruiting
  Biliary Tract Adenocarcinoma; Galbladder Adenocarcinoma
  
• Gemcitabine, Oxaliplatin in Combination with Bevacizumab in Patients with Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00142467 - Active, not recruiting
  Hepatocellular Carcinoma
  
• Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium
  ClinicalTrials.gov Identifier: NCT00310011 - Active, not recruiting
  Bladder Cancer; Transitional Cell Cancer of the Renal Pelvis and Ureter
  
• Gemcitabine, Paclitaxel, Doxorubicin, and Pegfilgrastim in Treating Patients With Metastatic or Unresectable Bladder Cancer or Urinary Tract Cancer and Kidney Dysfunction
  ClinicalTrials.gov Identifier: NCT00478361 - Recruiting
  Bladder Cancer; Neutropenia; Transitional Cell Cancer of the Renal Pelvis and Ureter; Urethral Cancer
  
• Gemcitabine, Paclitaxel, Ifosfamide, and Cisplatin in Treating Patients With Progressive or Relapsed Metastatic Germ Cell Tumors
  ClinicalTrials.gov Identifier: NCT00551122 - Recruiting
  Brain and Central Nervous System Tumors; Extragonadal Germ Cell Tumor; Ovarian Cancer; Testicular Germ Cell Tumor
  
• Gemcitabine/ Trastuzumab and Gemcitabine/ Cisplatin/ Trastuzumab in Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00201760 - Recruiting
  Breast Cancer
  
• Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00551096 - Recruiting
  Advanced Solid Tumors; Biliary Cancer; Pancreatic Cancer
  
• Gemcitabine/Cisplatin +/-Cetuximab in Patients With Locally Advanced or Metastatic EGFR-Positive Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00536614 - Completed
  Pancreatic Cancer
  
• Gemcitabine/Cisplatin Vs Gemcitabine/Epirubicin for NSCLC
  ClinicalTrials.gov Identifier: NCT00154739 - Recruiting
  Non-small cell lung cancer
  
• Gemcitabine/Irinotecan/ZD1839 vs Paclitaxel/Carboplatin/Etoposide/ZD1839 in Carcinoma of Unknown Primary Site
  ClinicalTrials.gov Identifier: NCT00193596 - Recruiting
  Neoplasms, Unknown Primary
  
• Gemcitabine/Oxaliplatin (GEMOX) vs Carboplatin/Paclitaxel (CP) in Non-small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00087802 - Active, not recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00191230 - Completed
  Carcinoma, Non Small Cell Lung
  
• Gemcitabine/Vinorelbine Versus Gemcitabine/Cisplatin Versus Gemcitabine/Capecitabine in Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00480597 - Active, not recruiting
  Metastatic Breast Cancer
  
• Gemox as First and Second Line Therapy in Unknown Primary Cancer
  ClinicalTrials.gov Identifier: NCT00353145 - Active, not recruiting
  Unknown Primary Neoplasms
  
• GEMOX: Oxaliplatin in Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00261092 - Completed
  Pancreatic Neoplasms
  
• Gemtuzumab and Combination Chemothearpy in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00551460 - Not yet recruiting
  Leukemia
  
• Gemtuzumab in Treating Patients With Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00022321 - Active, not recruiting
  Refractory Anemia; de novo myelodysplastic syndromes; refractory anemia with ringed sideroblasts; ...
  
• Gemtuzumab Ozogamicin and Cyclosporine in Treating Older Patients With Relapsed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00089050 - Completed
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia
  
• Gemtuzumab Ozogamicin and High-Dose Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00006265 - Active, not recruiting
  recurrent adult acute myeloid leukemia
  
• Gemtuzumab Ozogamicin Before Allogeneic Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00460447 - Recruiting
  Acute Myeloid Leukemia; Allogeneic Transplantation
  
• Gemtuzumab Ozogamicin in Combination with A-HAM in Refractory AML (GO-A-HAM)
  ClinicalTrials.gov Identifier: NCT00143975 - Active, not recruiting
  Leukemia, Myeloid, Acute
  
• Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00091234 - Active, not recruiting
  adult acute erythroid leukemia; adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• Gemtuzumab Ozogamicin in Treating Patients With Relapsed Acute Myeloid Leukemia After Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00053274 - Completed
  recurrent adult acute myeloid leukemia; recurrent childhood acute myeloid leukemia; secondary acute myeloid leukemia
  
• Gemtuzumab Ozogamicin in Treating Young Patients With Newly Diagnosed Acute Myeloid Leukemia Undergoing Remission Induction and Intensification Therapy
  ClinicalTrials.gov Identifier: NCT00070174 - Completed
  childhood acute monocytic leukemia; childhood acute myeloid leukemia
  
• Gemtuzumab Ozogamicin Plus Cytarabine in Treating Patients With Relapsed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00049179 - Active, not recruiting
  adult acute monoblastic and acute monocytic leukemia; adult acute myeloid leukemia; secondary acute myeloid leukemia
  
• Gemtuzumab Ozogamicin With or Without Chemotherapy in Treating Older Patients With Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00006122 - Active, not recruiting
  untreated adult acute myeloid leukemia; adult acute differentiated monocytic leukemia (M5b); ...
  
• Gemtuzumab Ozogamicin, Fludarabine, and Total-body Irradiation Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome
  ClinicalTrials.gov Identifier: NCT00008151 - Active, not recruiting
  Previously Treated Myelodysplastic Syndrome; secondary myelodysplastic syndrome; recurrent adult acute myeloid leukemia; ...
  
• Gemzar (gemcitabine) and Alimta (pemetrexed) in the Treatment of Patients with Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00055432 - Terminated
  Ovarian Cancer; Peritoneal Cancer
  
• Gemzar and Platinol followed by Alimta and Gemzar in Patients with Advanced or Metastatic Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00101842 - Completed
  Carcinoma, Transitional Cell
  
• Genasense™ (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects with Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00078234 - Active, not recruiting
  Chronic Lymphocytic Leukemia
  
• Gender Differences in Familial Risk
  ClinicalTrials.gov Identifier: NCT00005355 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Gender Response To Coronary Risk
  ClinicalTrials.gov Identifier: NCT00005224 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease
  
• Gender, Obesity, C-Reactive Protein, and Oxidative Stress
  ClinicalTrials.gov Identifier: NCT00079963 - Active, not recruiting
  Cardiovascular Disease
  
• Gender, Pain, and Placebo Analgesia
  ClinicalTrials.gov Identifier: NCT00314392 - Recruiting
  Experimental Pain
  
• Gender-Responsove Treatment for Women Offenders - 1
  ClinicalTrials.gov Identifier: NCT00249613 - Recruiting
  Outpatient Treatment; Substance Dependence
  
• Gene Analysis of Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00001643 - Active, not recruiting
  Parkinson's Disease
  
• Gene Changes and Biomarkers in Chronic Myeloproliferative Disorders
  ClinicalTrials.gov Identifier: NCT00433862 - Recruiting
  Polycythemia Vera; Essential Thrombocytosis; Idiopathic Myelofibrosis; Neutrophils; Chronic Myeloproliferative Disorders
  
• Gene Changes and Risk Factors in Nuclear Workers in Mayak, Russia
  ClinicalTrials.gov Identifier: NCT00342901 - Recruiting
  Unspecified Adult Solid Tumor, Protocol Specific
  
• Gene Damage Following Chemotherapy in Women With Stage II or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00003095 - Completed
  stage III breast cancer; stage II breast cancer
  
• Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy Regimen
  ClinicalTrials.gov Identifier: NCT00250029 - Completed
  Colonic Diseases; Cancer
  
• Gene Expression and Inflammation in Overweight Subjects
  ClinicalTrials.gov Identifier: NCT00344266 - Recruiting
  Overweight; Weight Loss
  
• Gene Expression in MS Patients Before and During Treatment With Interferon-Beta
  ClinicalTrials.gov Identifier: NCT00202384 - Recruiting
  Multiple Sclerosis
  
• Gene Expression in Predicting Treatment Response in Patients Receiving Gemcitabine With or Without Bevacizumab for Locally Advanced Unresectable or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00429858 - Recruiting
  Pancreatic Cancer
  
• Gene Expression Profiles in Predicting Chemotherapy Response in Breast Cancer
  ClinicalTrials.gov Identifier: NCT00212082 - Active, not recruiting
  Metastatic Breast Cancer
  
• Gene Expression Profiling and Bioinformatic Analysis Identifying Genes and Biochemical Pathways in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00143013 - Recruiting
  Type 2 Diabetes
  
• Gene Expression Profiling and Phototoxicity in Adults and Children Exposed to Ultraviolet Radiation
  ClinicalTrials.gov Identifier: NCT00411008 - Recruiting
  Drug Toxicity
  
• Gene Expression Profiling in Patients With Invasive Bladder Cancer Receiving Methotrexate, Vinblastine, Doxorubicin, and Cisplatin
  ClinicalTrials.gov Identifier: NCT00516750 - Recruiting
  Bladder Cancer
  
• Gene Expression Profiling in PBMCs as a Tool for Prediction of Anakinra Responsiveness in Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00213538 - Recruiting
  Rheumatoid Arthritis
  
• Gene Expression Profiling in PBMCs as a Tool for Prediction of Infliximab Responsiveness in Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00213564 - Recruiting
  Rheumatoid Arthritis
  
• Gene Expression Profiling in Type 1 Diabetes
  ClinicalTrials.gov Identifier: NCT00330954 - Recruiting
  Type 1 Diabetes Mellitus
  
• Gene Mapping for Quantitative Traits
  ClinicalTrials.gov Identifier: NCT00005535 - Completed
  Cardiovascular Diseases; Heart Diseases
  
• Gene Marked Cytotoxic T-cells for Patients with Relapsed Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00062868 - Recruiting
  Hodgkin Disease
  
• Gene Message (mRNA) Analysis of Granulocytes
  ClinicalTrials.gov Identifier: NCT00059423 - Recruiting
  Neutropenia
  
• Gene Modified Allogeneic Neuroblastoma Cells For Treatment of Relapsed/Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00186862 - Completed
  Neuroblastoma
  
• Gene Modifiers in Cystic Fibrosis Lung Disease
  ClinicalTrials.gov Identifier: NCT00037765 - Active, not recruiting
  Cystic Fibrosis; Lung Diseases
  
• Gene Mutations and Orthopaedic Symptoms Correlation of Multiple Hereditary Exostoses: Multicentre Project
  ClinicalTrials.gov Identifier: NCT00474331 - Recruiting
  Exostoses, Multiple Hereditary
  
• Gene Mutations in Patients With Advanced Prostate Cancer That Is Not Responsive to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00002924 - Completed
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• Gene Mutations in Patients With Melanoma and Their Families in Italy
  ClinicalTrials.gov Identifier: NCT00556829 - Recruiting
  Melanoma (Skin)
  
• Gene Mutations in Secondary Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00348803 - Recruiting
  Chronic Thromboembolic Pulmonary Hypertension
  
• Gene Polymorphisms and Symptoms in Lung Cancer Patients
  ClinicalTrials.gov Identifier: NCT00504374 - Recruiting
  Lung Cancer
  
• Gene Polymorphisms Influencing Steroid Synthesis and Action
  ClinicalTrials.gov Identifier: NCT00485186 - Recruiting
  Disorders of Sex Development; Congenital Adrenal Hyperplasia; Congenital Adrenal Hypoplasia; Adrenal Insufficiency; Mineralocorticoid Deficiency
  
• Gene Regulation by Thiazolidinediones
  ClinicalTrials.gov Identifier: NCT00567593 - Recruiting
  Inflammatory Bowel Disease
  
• Gene Testing in Patients With Colon Cancer
  ClinicalTrials.gov Identifier: NCT00003571 - Completed
  stage III colon cancer; adenocarcinoma of the colon
  
• Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors
  ClinicalTrials.gov Identifier: NCT00003096 - Completed
  untreated childhood supratentorial primitive neuroectodermal tumors; untreated childhood medulloblastoma
  
• Gene Therapy and Biological Therapy in Treating Patients With Ovarian Epithelial Cancer
  ClinicalTrials.gov Identifier: NCT00019136 - Completed
  Ovarian Cancer
  
• Gene Therapy and Ganciclovir in Treating Patients With Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00005057 - Completed
  Stage IV Melanoma; nodular malignant melanoma; Recurrent Melanoma; acral lentiginous malignant melanoma; lentigo maligna malignant melanoma; ...
  
• Gene Therapy and Surgery Followed by Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Cancer of the Mouth or Throat
  ClinicalTrials.gov Identifier: NCT00017173 - Active, not recruiting
  Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer
  
• Gene Therapy and Vaccine Treatment to Treat Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00088439 - Recruiting
  
  
• Gene Therapy Combined With Chemotherapy and Radiation Therapy in Treating Patients With Pancreatic Cancer That Cannot Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00049647 - No longer recruiting
  adenocarcinoma of the pancreas; stage III pancreatic cancer
  
• Gene Therapy for Alzheimer's Disease Clinical Trial
  ClinicalTrials.gov Identifier: NCT00017940 - Completed
  Alzheimer Disease
  
• Gene Therapy for Chronic Granulomatous Disease
  ClinicalTrials.gov Identifier: NCT00394316 - Recruiting
  Chronic Granulomatous Disease
  
• Gene Therapy for Chronic Granulomatous Disease
  ClinicalTrials.gov Identifier: NCT00564759 - Active, not recruiting
  Granulomatous Disease, Chronic
  
• Gene Therapy for Chronic Granulomatous Diseases - Long-term Follow-up
  ClinicalTrials.gov Identifier: NCT00001476 - Active, not recruiting
  Chronic Granulomatous Disease; Communicable Disease
  
• Gene Therapy for Gaucher's and Fabry Disease Using Viruses and Blood-Forming Cells
  ClinicalTrials.gov Identifier: NCT00001234 - Completed
  Gaucher's Disease
  
• Gene Therapy for Gyrate Atrophy
  ClinicalTrials.gov Identifier: NCT00001735 - Completed
  Gyrate Atrophy
  
• Gene Therapy for Patients with Leukocyte Adherence Deficiency (Follow-Up of Phase 1 Trial)
  ClinicalTrials.gov Identifier: NCT00023010 - Active, not recruiting
  Leukocyte Adhesion Deficiency Syndrome
  
• Gene Therapy for Pleural Malignancies
  ClinicalTrials.gov Identifier: NCT00299962 - Recruiting
  Pleural Mesothelioma; Metastatic Pleural Effusions
  
• Gene Therapy for Prostate Cancer that Returns after Radiation Therapy
  ClinicalTrials.gov Identifier: NCT00110526 - Recruiting
  Prostatic Neoplasms; Neoplasm Recurrence, Local
  
• Gene Therapy for the Treatment of Brain Tumors
  ClinicalTrials.gov Identifier: NCT00001328 - Active, not recruiting
  Brain Neoplasm; Neoplasm Metastasis
  
• Gene Therapy for the Treatment of Fanconi's Anemia Type C
  ClinicalTrials.gov Identifier: NCT00001399 - Active, not recruiting
  Fanconi's Anemia; Pancytopenia
  
• Gene Therapy in HIV-Positive Patients with Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00002221 - Completed
  Lymphoma, Non-Hodgkin; HIV Infections
  
• Gene Therapy in Patients With Colon Cancer That Has Spread to the Liver
  ClinicalTrials.gov Identifier: NCT00012155 - Active, not recruiting
  recurrent colon cancer; liver metastases; stage IV colon cancer; adenocarcinoma of the colon
  
• Gene Therapy in Preventing Cancer in Patients With Premalignant Carcinoma of the Oral Cavity or Pharynx
  ClinicalTrials.gov Identifier: NCT00064103 - Completed
  lip and oral cavity cancer; Oropharyngeal Cancer; stage 0 lip and oral cavity cancer; stage 0 oropharyngeal cancer
  
• Gene Therapy in Treating Children With Refractory or Recurrent Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002748 - Active, not recruiting
  recurrent neuroblastoma
  
• Gene Therapy in Treating Children With Relapsed or Refractory Neuroblastoma
  ClinicalTrials.gov Identifier: NCT00002713 - Completed
  recurrent neuroblastoma
  
• Gene Therapy in Treating Patients With Advanced Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00003167 - Completed
  stage III bladder cancer; stage II bladder cancer; transitional cell carcinoma of the bladder; stage I bladder cancer; recurrent bladder cancer; ...
  
• Gene Therapy in Treating Patients With Advanced Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00009841 - Active, not recruiting
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Gene Therapy in Treating Patients With Advanced Recurrent or Persistent Ovarian Cancer or Primary Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00003450 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage IV ovarian epithelial cancer
  
• Gene Therapy in Treating Patients With Cancer
  ClinicalTrials.gov Identifier: NCT00004178 - Active, not recruiting
  Lung Cancer; Pancreatic Cancer; Gastric Cancer; Salivary Gland Cancer; Renal Cell Cancer; Endometrial Cancer; Esophageal Cancer; Head and Neck Cancer; ...
  
• Gene Therapy in Treating Patients With Cancer of The Liver
  ClinicalTrials.gov Identifier: NCT00003147 - Active, not recruiting
  adult primary hepatocellular carcinoma; localized unresectable adult primary liver cancer
  
• Gene Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00005943 - Active, not recruiting
  Stage IV Melanoma; Recurrent Melanoma
  
• Gene Therapy in Treating Patients With Non-small Cell Lung Cancer That Cannot Be Surgically Removed
  ClinicalTrials.gov Identifier: NCT00003649 - Completed
  stage IV non-small cell lung cancer; Bronchoalveolar Cell Lung Cancer; stage IIIB non-small cell lung cancer; recurrent non-small cell lung cancer
  
• Gene Therapy in Treating Patients With Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00003588 - Completed
  recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Gene Therapy in Treating Patients With Primary Brain Tumors
  ClinicalTrials.gov Identifier: NCT00002824 - Completed
  Brain Tumor; Glioblastoma; Astrocytoma
  
• Gene Therapy in Treating Patients With Recurrent Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00003257 - Active, not recruiting
  recurrent squamous cell carcinoma of the hypopharynx; recurrent squamous cell carcinoma of the larynx; ...
  
• Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
  ClinicalTrials.gov Identifier: NCT00004041 - Completed
  recurrent adult brain tumor; adult anaplastic oligodendroglioma; adult glioblastoma multiforme; adult anaplastic astrocytoma; Mixed Gliomas
  
• Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors
  ClinicalTrials.gov Identifier: NCT00004080 - Completed
  recurrent adult brain tumor; adult glioblastoma multiforme; adult anaplastic astrocytoma; Mixed Gliomas
  
• Gene Therapy in Treating Patients With Recurrent or Progressive Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00036725 - Active, not recruiting
  recurrent adult brain tumor; adult glioblastoma multiforme
  
• Gene Therapy in Treating Patients With Stage III or Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00003646 - Active, not recruiting
  Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
  
• Gene Therapy in Treating Patients With Unresectable, Recurrent, or Refractory Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00004070 - Active, not recruiting
  lip and oral cavity cancer; Head and Neck Cancer; Oropharyngeal Cancer
  
• Gene Therapy in Treating Women With Refractory or Relapsed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer
  ClinicalTrials.gov Identifier: NCT00005025 - Active, not recruiting
  recurrent ovarian epithelial cancer; peritoneal cavity cancer; Fallopian Tube Cancer
  
• Gene Therapy Plus Chemotherapy in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003567 - Completed
  adult brain tumor; adult non-Hodgkin's lymphoma; adult solid tumor
  
• Gene Therapy Plus Chemotherapy in Treating Patients With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00004038 - Completed
  stage I breast cancer; stage IIIB breast cancer; stage IIIA breast cancer; stage IV breast cancer; recurrent breast cancer; stage II breast cancer
  
• Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00004225 - Completed
  recurrent non-small cell lung cancer
  
• Gene Therapy to Improve Wound Healing in Patients With Diabetes
  ClinicalTrials.gov Identifier: NCT00065663 - Completed
  Wounds and Injuries; Diabetes; Diabetic Foot Ulcers; Foot wounds
  
• Gene Therapy With GX-12 in Combination With HAART for the HIV-1 Infected Patients
  ClinicalTrials.gov Identifier: NCT00517569 - Recruiting
  HIV Infections
  
• Gene Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With HIV-Related Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00003942 - Active, not recruiting
  AIDS-related diffuse small cleaved cell lymphoma; AIDS-related small noncleaved cell lymphoma; AIDS-related lymphoblastic lymphoma; ...
  
• Gene Therapy-Treated Stem Cells in Treating Patients Undergoing Stem Cell Transplant for Intermediate-Grade or High-Grade AIDS-Related Lymphoma
  ClinicalTrials.gov Identifier: NCT00569985 - Recruiting
  Lymphoma
  
• Gene Transfer for Subjects With Hemophilia B Factor IX Deficiency
  ClinicalTrials.gov Identifier: NCT00515710 - Recruiting
  Hemophilia B
  
• Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) due to Adenosine Deaminase (ADA) Deficiency
  ClinicalTrials.gov Identifier: NCT00018018 - Recruiting
  Severe Combined Immunodeficiency Syndrome
  
• Gene Transfer Therapy for Severe Combined Immunodeficieny Disease (SCID) due to Adenosine Deaminase (ADA) Deficiency: A Natural History Study
  ClinicalTrials.gov Identifier: NCT00001255 - Completed
  Severe Combined Immunodeficiency
  
• Gene Transfer Therapy for Treating Children and Adults With Limb Girdle Muscular Dystrophy Type 2D (LGMD2D)
  ClinicalTrials.gov Identifier: NCT00494195 - Recruiting
  Muscular Dystrophies
  
• Gene-by-Smoking Interactions and Risk of Atherosclerosis - Ancillary to ARIC
  ClinicalTrials.gov Identifier: NCT00064545 - Active, not recruiting
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases; Coronary Disease; Carotid Artery Diseases; Peripheral Vascular Diseases; ...
  
• Gene-Environment Interaction in Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00041847 - Recruiting
  Prostate Cancer
  
• Gene-Environment Interactions in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00018473 - Completed
  Alzheimer's Disease
  
• Gene-Environment Interactions in Complex Disease
  ClinicalTrials.gov Identifier: NCT00064506 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Atherosclerosis; Coronary Disease
  
• Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00085462 - Active, not recruiting
  Melanoma (Skin)
  
• Gene-Polymorphies in the P2X7 Gene in Patients With Osteoporotic Fractures
  ClinicalTrials.gov Identifier: NCT00293189 - Recruiting
  Hip Fracture
  
• Gene-Specific Responses to Exercise in Discordant Twins
  ClinicalTrials.gov Identifier: NCT00083837 - Active, not recruiting
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases
  
• Genentech National Cooperative Growth Study Surveillance Program for Nutropin AQ, Nutropin, and Protropin
  ClinicalTrials.gov Identifier: NCT00231361 - Recruiting
  Growth Disorders
  
• General Practice Quality Assurance Project– COPD Diagnosis and Treatment
  ClinicalTrials.gov Identifier: NCT00319813 - Recruiting
  COPD
  
• General Surgery Training Outcomes Project
  ClinicalTrials.gov Identifier: NCT00461214 - Recruiting
  Healthy
  
• Generalization of Training in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00108199 - Completed
  Schizophrenia; Schizoaffective Disorder
  
• Generalized Anxiety Disorder Adjunct Study
  ClinicalTrials.gov Identifier: NCT00534599 - Recruiting
  Anxiety; Anxiety Disorders; Anxiety Neuroses; Anxiety States
  
• Generalized Anxiety Disorder and Social Anxiety Disorder: Their Impact on the Processing of Information and Learning
  ClinicalTrials.gov Identifier: NCT00062517 - Recruiting
  Anxiety Disorders
  
• Generation of Anti-HCV Antibodies From Bone Marrow: Defining the Repertoire of Immune Response to HCV Quasispecies
  ClinicalTrials.gov Identifier: NCT00004851 - Completed
  Hepatitis C
  
• Generation of Standard Laboratory Values for Pneumococci Antibodies
  ClinicalTrials.gov Identifier: NCT00567632 - Active, not recruiting
  Reference Values
  
• Generic Data Base Study: A Registry of Very Low Birth Weight Infants
  ClinicalTrials.gov Identifier: NCT00063063 - Recruiting
  Infant, very low birth weight
  
• Generic vs. Name-Brand Levothyroxine
  ClinicalTrials.gov Identifier: NCT00403390 - Recruiting
  Congenital Hypothyroidism; Hypothyroidism
  
• Genes and Fibrinolytic Capacity of Human Endothelium
  ClinicalTrials.gov Identifier: NCT00139503 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Thrombosis; Blood Disease; Coronary Disease
  
• Genes as Predictors of Response to Gemcitabine, Docetaxel, and Capecitabine (GTX) in Metastatic or Unresectable Pancreatic Cancer.
  ClinicalTrials.gov Identifier: NCT00159471 - Recruiting
  Pancreatic Cancer
  
• Genes Associated with Hereditary and Drug-Induced Gingival Overgrowth
  ClinicalTrials.gov Identifier: NCT00104026 - Recruiting
  
  
• Genes Causing Ebstein's Anomaly
  ClinicalTrials.gov Identifier: NCT00497705 - Recruiting
  Heart Septal Defects, Ventricle; Heart Defects, Congenital; Double Outlet Right Ventricle; Truncus Arteriosus, Persistent
  
• Genes in Predicting Outcome of Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab and Combination Chemotherapy
  ClinicalTrials.gov Identifier: NCT00450385 - Recruiting
  Lymphoma
  
• Genes Involved in Resistance or Susceptibility to Hepatitis B Virus
  ClinicalTrials.gov Identifier: NCT00342186 - Recruiting
  Hepatitis B
  
• Genes Mutation Pentalogy of Cantrell
  ClinicalTrials.gov Identifier: NCT00477932 - Recruiting
  Pentalogy of Cantrell; Mutations in Non-Muscle Genes
  
• Genes of Hypertension in African Americans
  ClinicalTrials.gov Identifier: NCT00063505 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Genes That Affect Disease Outcome in Patients With Metastatic Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00467129 - Active, not recruiting
  Colorectal Cancer
  
• Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00463034 - Recruiting
  Breast Cancer
  
• Genesis of Scleroderma: Role of Environmental Factors in 100 Patients With Scleroderma and 300 Controls
  ClinicalTrials.gov Identifier: NCT00213525 - Recruiting
  Scleroderma
  
• Genetic Abnormalities and Biological Changes of Panic Disorder Patients After Pharmacotherapy
  ClinicalTrials.gov Identifier: NCT00515996 - Recruiting
  Panic Disorder
  
• Genetic Abnormalities and Oxidative Stress in Sperm as Cause of Recurrent Miscarriage.
  ClinicalTrials.gov Identifier: NCT00447395 - Recruiting
  Recurrent Miscarriage
  
• Genetic Analysis for Predicting of Relapse During Steroid Treatment for Autoimmune Pancreatitis (AIP)
  ClinicalTrials.gov Identifier: NCT00444444 - Completed
  Pancreatitis
  
• Genetic Analysis in Diagnosing Thyroid Cancer in Patients With Thyroid Nodules
  ClinicalTrials.gov Identifier: NCT00316823 - Recruiting
  Head and Neck Cancer
  
• Genetic Analysis of African-Americans With High Blood Pressure
  ClinicalTrials.gov Identifier: NCT00353925 - Completed
  Hypertension
  
• Genetic Analysis of Attention Deficit Hyperactivity Disorder (ADHD)
  ClinicalTrials.gov Identifier: NCT00046059 - Recruiting
  Attention Deficit Disorder with Hyperactivity
  
• Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00033137 - Recruiting
  Syndrome
  
• Genetic Analysis of Brain Disorders
  ClinicalTrials.gov Identifier: NCT00341978 - Recruiting
  Brain Disorders
  
• Genetic Analysis of Brain Tumors
  ClinicalTrials.gov Identifier: NCT00031538 - Recruiting
  Glioma
  
• Genetic Analysis of Craniofrontonasal Syndrome
  ClinicalTrials.gov Identifier: NCT00339846 - Active, not recruiting
  Craniofrontonasal Syndrome; CFNS
  
• Genetic Analysis of Craniosynostosis, Philadelphia Type
  ClinicalTrials.gov Identifier: NCT00367796 - Active, not recruiting
  Craniosynostosis; Philadelphia Type Craniosynostosis
  
• Genetic Analysis of Familial Brain Aneurysms
  ClinicalTrials.gov Identifier: NCT00011856 - Completed
  Intracranial Aneurysm
  
• Genetic Analysis of Familial Hypertrophic Cardiomyopathy
  ClinicalTrials.gov Identifier: NCT00005251 - Completed
  Cardiovascular Diseases; Heart Diseases; Myocardial Diseases; Cardiomyopathy, Hypertrophic
  
• Genetic Analysis of Familial Keloids
  ClinicalTrials.gov Identifier: NCT00008502 - Recruiting
  Keloid
  
• Genetic Analysis of Familial Melanoma
  ClinicalTrials.gov Identifier: NCT00339404 - Recruiting
  Melanoma
  
• Genetic Analysis of Fraser Syndrome and Fryns Syndrome
  ClinicalTrials.gov Identifier: NCT00032877 - Completed
  Fraser Syndrome; Fryns Syndrome; Chromosomal Abnormalities; Abnormalities, Multiple
  
• Genetic Analysis of Gray Platelet Syndrome
  ClinicalTrials.gov Identifier: NCT00069680 - Recruiting
  Genetic Linkage; Myelofibrosis
  
• Genetic Analysis of Hereditary Disorders of Hearing and Balance
  ClinicalTrials.gov Identifier: NCT00023049 - Recruiting
  Sensorineural Hearing Loss; Hearing Disorder; Vestibular Disease
  
• Genetic Analysis of Hereditary Non-Syndromic Oral Clefts
  ClinicalTrials.gov Identifier: NCT00340626 - Recruiting
  Hereditary Oral Clefts
  
• Genetic Analysis of Hereditary Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00001469 - Recruiting
  Hereditary Neoplastic Syndrome; Prostatic Neoplasm
  
• Genetic Analysis of Human Hereditary Hearing Impairment
  ClinicalTrials.gov Identifier: NCT00001606 - Recruiting
  Partial Hearing Loss
  
• Genetic Analysis of Human Hypertensive End Stage Renal Disease (H-ESRD)
  ClinicalTrials.gov Identifier: NCT00005536 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Kidney Failure, Chronic
  
• Genetic Analysis of Immune Disorders
  ClinicalTrials.gov Identifier: NCT00001467 - Recruiting
  Healthy; Immunologic Deficiency Syndrome; Job's Syndrome; Severe Combined Immunodeficiency
  
• Genetic Analysis of Inherited Urologic Malignant Disorders: Collection of Samples
  ClinicalTrials.gov Identifier: NCT00001814 - Completed
  Neoplastic Syndromes, Hereditary; Urologic Neoplasms
  
• Genetic Analysis of Left-Right Axis Formations
  ClinicalTrials.gov Identifier: NCT00341133 - Active, not recruiting
  Congenital Heart Disease
  
• Genetic Analysis of Neural Tube and Orofacial Cleft Defects in the Irish Population
  ClinicalTrials.gov Identifier: NCT00341068 - Active, not recruiting
  Neural Tube Defects (NTDs); Facial Cleft Defect
  
• Genetic Analysis of Oculocerebrorenal Syndrome of Lowe
  ClinicalTrials.gov Identifier: NCT00359515 - Active, not recruiting
  Lowe Syndrome
  
• Genetic Analysis of Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00001640 - Active, not recruiting
  Parkinson's Disease
  
• Genetic Analysis of Patients With Pseudoxanthoma Elasticum
  ClinicalTrials.gov Identifier: NCT00341419 - Recruiting
  Pseudoxanthoma Elasticum; PXE
  
• Genetic Analysis of Psoriasis and Psoriatic Arthritis
  ClinicalTrials.gov Identifier: NCT00341809 - Active, not recruiting
  Psoriasis
  
• Genetic Analysis of the Chiari I Malformation
  ClinicalTrials.gov Identifier: NCT00004738 - Recruiting
  Syringomyelia; Type I Arnold Chiari Malformation
  
• Genetic Analysis of Thyrotoxic Periodic Paralysis
  ClinicalTrials.gov Identifier: NCT00443833 - Completed
  Thyrotoxic Periodic Paralysis
  
• Genetic Analysis Using Blood or Bone Marrow From Participants With Neuroblastoma or Noncancerous Conditions
  ClinicalTrials.gov Identifier: NCT00436696 - Recruiting
  Neuroblastoma
  
• Genetic and Biochemical Markers of Interferon-Induced Depression.
  ClinicalTrials.gov Identifier: NCT00252538 - Recruiting
  Hepatitis; Depression
  
• Genetic and Clinical Study of Patients With Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
  ClinicalTrials.gov Identifier: NCT00004044 - Recruiting
  Head and Neck Cancer; Intraocular Melanoma; Melanoma (Skin); Non-Melanomatous Skin Cancer; Precancerous/Nonmalignant Condition
  
• Genetic and Environmental Determinants of Hypertension
  ClinicalTrials.gov Identifier: NCT00005149 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Genetic and Environmental Determinants of Triglycerides (GOLDN)
  ClinicalTrials.gov Identifier: NCT00083369 - Active, not recruiting
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases
  
• Genetic and Environmental Pathogenesis of PPH
  ClinicalTrials.gov Identifier: NCT00091546 - Recruiting
  Lung Diseases; Hypertension, Pulmonary
  
• Genetic and Environmental Risk Assessment for Colorectal Cancer in Healthy Participants
  ClinicalTrials.gov Identifier: NCT00087360 - Completed
  Colon Cancer; Rectal Cancer
  
• Genetic and Environmental Risk Factors for Esophageal Cancer in Patients With Esophageal Cancer and in Healthy Participants in Northern Iran
  ClinicalTrials.gov Identifier: NCT00544843 - Recruiting
  Esophageal Cancer; Healthy, no Evidence of Disease
  
• Genetic and Environmental Risk Factors in African American and Caucasian Healthy Men and in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00556725 - Recruiting
  Prostate Cancer
  
• Genetic and Epidemiologic Studies of Premature Coronary Artery Disease - SCOR in Arteriosclerosis
  ClinicalTrials.gov Identifier: NCT00005324 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease
  
• Genetic and Family Studies of Inherited Muscle Diseases
  ClinicalTrials.gov Identifier: NCT00001331 - Completed
  Dermatomyositis; Glycogen Storage Disease Type II; Glycogen Storage Disease Type VII; Myositis; Polymyositis
  
• Genetic and Immune Studies of Rheumatoid Arthritis and Related Conditions
  ClinicalTrials.gov Identifier: NCT00001291 - Completed
  Arthritis, Psoriatic; Autoimmune Diseases; Joint Diseases; Osteoarthritis; Rheumatoid Arthritis
  
• Genetic and Nutritional Causes of Heart Birth Defects
  ClinicalTrials.gov Identifier: NCT00368732 - Completed
  Heart Defects, Congenital
  
• Genetic and Physical Characteristics of Rett Syndrome
  ClinicalTrials.gov Identifier: NCT00299312 - Recruiting
  Rett Syndrome
  
• Genetic and Protein Profiling in Normal and Cancerous Breast Tissue
  ClinicalTrials.gov Identifier: NCT00083733 - Recruiting
  Breast Neoplasms
  
• Genetic Architecture of Heart Disease in Rural Brazil
  ClinicalTrials.gov Identifier: NCT00023556 - Active, not recruiting
  Chagas Disease; Heart Diseases; Arrhythmia; Heart Failure, Congestive
  
• Genetic Architecture of Plasma T-PA and PAI-1
  ClinicalTrials.gov Identifier: NCT00007410 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Thrombosis; Atherosclerosis
  
• Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families
  ClinicalTrials.gov Identifier: NCT00341627 - Active, not recruiting
  Chordoma
  
• Genetic Aspects of Neurologic and Psychiatric Disorders
  ClinicalTrials.gov Identifier: NCT00001544 - Completed
  Attention Deficit Disorder with Hyperactivity; Bipolar Disorder; Mental Disorder Diagnosed in Childhood; Mental Retardation; Schizophrenia
  
• Genetic Basis For Variation In NSAID Analgesia In A Clinical Model Of Acute Pain
  ClinicalTrials.gov Identifier: NCT00115752 - Completed
  
  
• Genetic Basis for Variation in the Renal Elimination of Metformin
  ClinicalTrials.gov Identifier: NCT00187720 - Recruiting
  Healthy Volunteer
  
• Genetic Basis of Abdominal Aortic Aneurysm
  ClinicalTrials.gov Identifier: NCT00005526 - Completed
  Cardiovascular Diseases; Heart Diseases; Aortic Aneurysm, Abdominal
  
• Genetic Basis of Hemangiomas
  ClinicalTrials.gov Identifier: NCT00466375 - Recruiting
  Hemangioma
  
• Genetic Basis of Immunodeficiency
  ClinicalTrials.gov Identifier: NCT00055172 - Recruiting
  Severe Combined Immunodeficiency
  
• Genetic Basis of Primary Immunodeficiencies
  ClinicalTrials.gov Identifier: NCT00001788 - Recruiting
  Immunologic Deficiency Syndrome
  
• Genetic Causes of Clubfoot
  ClinicalTrials.gov Identifier: NCT00474344 - Recruiting
  Clubfoot
  
• Genetic Causes of Male Infertility
  ClinicalTrials.gov Identifier: NCT00341120 - Recruiting
  Male Infertility
  
• Genetic Causes of Panic Disorder
  ClinicalTrials.gov Identifier: NCT00083265 - Recruiting
  Panic Disorder
  
• Genetic Changes in Patients With Non-Small Cell Lung Cancer Who Are Receiving Vinorelbine and Gemcitabine Before Surgery
  ClinicalTrials.gov Identifier: NCT00057798 - Active, not recruiting
  stage I non-small cell lung cancer; stage II non-small cell lung cancer; stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
  
• Genetic Characterisation of High-Grade Paediatric Osteosarcomas
  ClinicalTrials.gov Identifier: NCT00223184 - Recruiting
  Presence of Molecular Abnormalities Statistically Linked to Survival or Response to Chemotherapy
  
• Genetic Characterization of Individuals With Limb Girdle Muscular Dystrophy
  ClinicalTrials.gov Identifier: NCT00457912 - Recruiting
  Limb Girdle Muscular Dystrophy
  
• Genetic Characterization of Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00105131 - Completed
  
  
• Genetic Component of Handedness
  ClinicalTrials.gov Identifier: NCT00005003 - Completed
  Healthy
  
• Genetic Counseling for Menopausal Therapy Decision-Making for Women at Increased Risk for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00349011 - Completed
  Menopause
  
• Genetic Counseling in African American Women
  ClinicalTrials.gov Identifier: NCT00419510 - Recruiting
  Breast Cancer; Ovarian Cancer
  
• Genetic Counseling in Women at Risk for BRCA1 or BRCA2 Mutations
  ClinicalTrials.gov Identifier: NCT00416754 - Active, not recruiting
  Breast Cancer
  
• Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions
  ClinicalTrials.gov Identifier: NCT00262899 - Recruiting
  Breast Cancer; Psychosocial Effects/Treatment
  
• Genetic Counselors' Experiences of Moral Value Conflicts With Clients
  ClinicalTrials.gov Identifier: NCT00360711 - Completed
  Moral Value Conflicts; Moral Distress; Genetic Counseling
  
• Genetic Determinants of Ankylosing Spondylitis Severity
  ClinicalTrials.gov Identifier: NCT00056849 - Active, not recruiting
  Ankylosing Spondylitis
  
• Genetic Determinants of Ankylosing Spondylitis Severity - Longitudinal Study
  ClinicalTrials.gov Identifier: NCT00056719 - Recruiting
  Ankylosing Spondylitis
  
• Genetic Determinants of Opioids Analgesia
  ClinicalTrials.gov Identifier: NCT00226564 - Completed
  Nephrolithiasis
  
• Genetic Determinants of Sudden Cardiac Death
  ClinicalTrials.gov Identifier: NCT00064558 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Death, Sudden, Cardiac; Ventricular Arrhythmia; Arrhythmia
  
• Genetic Determinants of the Bronchodilatation Effect of Albuterol Ex-Vivo.
  ClinicalTrials.gov Identifier: NCT00162422 - Recruiting
  Asthma
  
• Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol Inhalation
  ClinicalTrials.gov Identifier: NCT00162487 - Recruiting
  Hyperkalemia; Chronic Renal Failure
  
• Genetic Determinants of the Response to Salbutamol Among Asthma Patients
  ClinicalTrials.gov Identifier: NCT00162396 - Recruiting
  Asthma
  
• Genetic Determinants of Warfarin Anticoagulation Effect
  ClinicalTrials.gov Identifier: NCT00162435 - Recruiting
  Venous Thrombosis; Pulmonary Embolism; Atrial Fibrillation
  
• Genetic Determinants:Low HDL, High Triglycerides, Obesity
  ClinicalTrials.gov Identifier: NCT00049881 - Completed
  Cardiovascular Diseases; Atherosclerosis; Hypertriglyceridemia; Obesity; Heart Diseases; Metabolic Syndrome X
  
• Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease
  ClinicalTrials.gov Identifier: NCT00368446 - Recruiting
  Mycobacteria, Atypical; Cystic Fibrosis; Ciliary Disorders; Pseudohypoaldosteronism; Bronchiectasis
  
• Genetic Drug Study of Mycophenolic Acid (CellCept) in Pediatric Kidney Transplant Patients
  ClinicalTrials.gov Identifier: NCT00433953 - Recruiting
  Kidney Transplant
  
• Genetic Epidemiological Study of Lung Cancer in Taiwan and Clinical Applications
  ClinicalTrials.gov Identifier: NCT00260871 - Recruiting
  Lung Cancer
  
• Genetic Epidemiology and Energy Metabolism in Black Girls
  ClinicalTrials.gov Identifier: NCT00014872 - Active, not recruiting
  Cardiovascular Diseases; Obesity
  
• Genetic Epidemiology of Adult Onset Glioma
  ClinicalTrials.gov Identifier: NCT00283569 - Recruiting
  Adult-Onset Glioma
  
• Genetic Epidemiology of Asthma in Costa Rica
  ClinicalTrials.gov Identifier: NCT00021840 - Active, not recruiting
  Asthma; Lung Diseases
  
• Genetic Epidemiology of Blood Lipids and Obesity - Ancillary to NGHS
  ClinicalTrials.gov Identifier: NCT00005345 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Obesity
  
• Genetic Epidemiology of Blood Pressure Intervention
  ClinicalTrials.gov Identifier: NCT00079690 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Genetic Epidemiology of Change in CVD Risk Factors
  ClinicalTrials.gov Identifier: NCT00037440 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases
  
• Genetic Epidemiology of CHD Risk Factors in Blacks
  ClinicalTrials.gov Identifier: NCT00005364 - Completed
  Cardiovascular Diseases; Heart Diseases; Coronary Disease
  
• Genetic Epidemiology of COPD in Costa Rica
  ClinicalTrials.gov Identifier: NCT00106470 - Recruiting
  Chronic Obstructive Pulmonary Disease; Lung Diseases, Obstructive
  
• Genetic Epidemiology of Coronary Heart Disease
  ClinicalTrials.gov Identifier: NCT00005209 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Coronary Disease
  
• Genetic Epidemiology of Coronary Heart Disease Risk in Women Twins
  ClinicalTrials.gov Identifier: NCT00005239 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases
  
• Genetic Epidemiology of CVD Risk Factors
  ClinicalTrials.gov Identifier: NCT00053521 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases
  
• Genetic Epidemiology of Familial Amyotrophic Lateral Sclerosis (ALS)
  ClinicalTrials.gov Identifier: NCT00317616 - Recruiting
  Amyotrophic Lateral Sclerosis
  
• Genetic Epidemiology of Hypertriglyceridemia
  ClinicalTrials.gov Identifier: NCT00005368 - Completed
  Cardiovascular Diseases; Coronary Disease; Hyperlipidemia, Familial Combined; Hyperlipoproteinemia Type IV
  
• Genetic Epidemiology of Lipoprotein-Lipid Levels
  ClinicalTrials.gov Identifier: NCT00005335 - Completed
  Cardiovascular Diseases; Heart Diseases; Atherosclerosis
  
• Genetic Epidemiology of Lung Cancer
  ClinicalTrials.gov Identifier: NCT00341835 - Recruiting
  Lung Cancer
  
• Genetic Epidemiology of Lung Cancer and Smoking
  ClinicalTrials.gov Identifier: NCT00340340 - Active, not recruiting
  Lung Cancer
  
• Genetic Epidemiology of Ovarian Aging
  ClinicalTrials.gov Identifier: NCT00501800 - Recruiting
  Infertility
  
• Genetic Epidemiology of Responses to Antihypertensives
  ClinicalTrials.gov Identifier: NCT00005520 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Genetic Epidemiology of Sarcoidosis
  ClinicalTrials.gov Identifier: NCT00005531 - Completed
  Lung Diseases; Sarcoidosis
  
• Genetic Epidemiology of Venous Thromboembolism
  ClinicalTrials.gov Identifier: NCT00005543 - Completed
  Cardiovascular Diseases; Venous Thromboembolism
  
• Genetic Epidemiology Risk Assessment Program or Usual Care in Colorectal Cancer Screening for Healthy Participants
  ClinicalTrials.gov Identifier: NCT00478309 - Recruiting
  Colorectal Cancer; Healthy, no Evidence of Disease
  
• Genetic Epidemiology--Development of Cardiovascular Risk
  ClinicalTrials.gov Identifier: NCT00005512 - Completed
  Cardiovascular Diseases; Hypertension; Obesity; Heart Diseases
  
• Genetic Expression and Prediction of Response to Neoadjuvant Docetaxel Or Doxorubicin in Locally Advanced Breast Cancer
  ClinicalTrials.gov Identifier: NCT00123929 - Recruiting
  Breast Cancer
  
• Genetic Factors Affecting the Severity of Beta Thalassemia
  ClinicalTrials.gov Identifier: NCT00159042 - Recruiting
  beta Thalassemia
  
• Genetic Factors and Interrelationships for Cancer Risk-Related Behaviors and Complex Traits
  ClinicalTrials.gov Identifier: NCT00001500 - Completed
  Acquired Immunodeficiency Syndrome; Alcoholism; HIV Infection; Neoplasm; Smoking
  
• Genetic Factors and Interrelationships for Sexual Orientation, Susceptibility to HIV and Kaposi's Sarcoma, Alcoholism and Psychological Traits, and Histocompatibility Antigens
  ClinicalTrials.gov Identifier: NCT00001294 - Completed
  Alcoholism; HIV Infection; Homosexuality; Kaposi's Sarcoma
  
• Genetic Factors in Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00058695 - Recruiting
  Macular Degeneration
  
• Genetic Factors in Atherosclerosis
  ClinicalTrials.gov Identifier: NCT00359307 - Active, not recruiting
  Atherosclerosis
  
• Genetic Factors Related to Stuttering
  ClinicalTrials.gov Identifier: NCT00001602 - Completed
  Stuttering
  
• Genetic Influence on Susceptibility to Type 1 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00001985 - Completed
  Diabetes Mellitus; Healthy
  
• Genetic Influences of Albuterol Response In Children With Bronchiolitis
  ClinicalTrials.gov Identifier: NCT00570297 - Recruiting
  Bronchiolitis
  
• Genetic Investigation of Pediatric Tumors of the Pituitary Gland
  ClinicalTrials.gov Identifier: NCT00001595 - Recruiting
  Abnormalities; Craniopharyngioma; Cushing's Syndrome; Endocrine Disease; Pituitary Neoplasm
  
• Genetic Liability in the Brain Morphology of Attention Deficit Hyperactivity Disorder
  ClinicalTrials.gov Identifier: NCT00161161 - Completed
  Attention Deficit Hyperactivity Disorder
  
• Genetic Linkage Studies of Stuttering
  ClinicalTrials.gov Identifier: NCT00001604 - Recruiting
  Stuttering
  
• Genetic Linkage Study for Hereditary Pancreatitis
  ClinicalTrials.gov Identifier: NCT00004475 - Recruiting
  Pancreatitis
  
• Genetic Mapping of Atherogenic Lipoprotein Phenotypes
  ClinicalTrials.gov Identifier: NCT00005465 - Completed
  Atherosclerosis; Cardiovascular Diseases; Heart Diseases
  
• Genetic Markers for Focal Segmental Glomerulosclerosis
  ClinicalTrials.gov Identifier: NCT00001393 - Recruiting
  AIDS Associated Nephropathy; Focal Glomerulosclerosis; HIV Infections
  
• Genetic Markers in Patients With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00014079 - Completed
  Colon Cancer; Rectal Cancer
  
• Genetic Markers of CHD Risk in Men and Women
  ClinicalTrials.gov Identifier: NCT00090454 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Infarction; Inflammation
  
• Genetic Markers of Coronary Heart Disease in Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00078052 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Diabetes Mellitus, non-insulin dependent; Diabetes Mellitus; Heart Diseases
  
• Genetic Measurements in Blood Cells of Children Taking Adderall or Methylphenidate
  ClinicalTrials.gov Identifier: NCT00341029 - Recruiting
  Attention Deficit Hyperactivity Disorder; ADHD
  
• Genetic Mechanisms of Chronic Obstructive Pulmonary Disease (COPD)
  ClinicalTrials.gov Identifier: NCT00018408 - Completed
  Chronic Obstructive Lung Disease
  
• Genetic Modifiers of Cystic Fibrosis: Sibling Study
  ClinicalTrials.gov Identifier: NCT00037778 - Recruiting
  Lung Diseases; Cystic Fibrosis
  
• Genetic Origin of Lipid Disorders
  ClinicalTrials.gov Identifier: NCT00277121 - Not yet recruiting
  Lipid Disorder
  
• Genetic Polymorphisms Associated With Cigarette Smoking and Risk of Graves’ Disease
  ClinicalTrials.gov Identifier: NCT00505011 - Completed
  Graves' Disease
  
• Genetic Polymorphisms in Idiopathic Pulmonary Fibrosis (IPF)
  ClinicalTrials.gov Identifier: NCT00258570 - Recruiting
  Pulmonary Fibrosis
  
• Genetic Predictors of Cardiovascular Disease
  ClinicalTrials.gov Identifier: NCT00339599 - Active, not recruiting
  Cardiovascular Disease
  
• Genetic Predictors of Incident Cardiovascular Disease
  ClinicalTrials.gov Identifier: NCT00035672 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases
  
• Genetic Predictors of Outcome in HCM Patients
  ClinicalTrials.gov Identifier: NCT00156429 - Recruiting
  Hypertrophic Cardiomyopathy
  
• Genetic Predisposition of Coronary Artery Disease -- The COROGENE-Study
  ClinicalTrials.gov Identifier: NCT00417534 - Recruiting
  Coronary Disease; Inflammation
  
• Genetic Registry for Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00069472 - Recruiting
  Rheumatoid Arthritis
  
• Genetic Research in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00108303 - Recruiting
  Schizophrenia
  
• Genetic Research of Bone Morphogenetic Protein Receptor-II Gene in Taiwanese Patient With Primary Pulmonary Hypertension
  ClinicalTrials.gov Identifier: NCT00173537 - Recruiting
  Pulmonary Hypertension
  
• Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome
  ClinicalTrials.gov Identifier: NCT00482794 - Recruiting
  Antiphospholipid Syndrome
  
• Genetic Risk Factors for Lung Cancer in Non-Smoking Women in Xuan Wei and Fu Yuan Counties in Yun Nan Province, China
  ClinicalTrials.gov Identifier: NCT00341926 - Recruiting
  Lung Cancer
  
• Genetic Risk Factors for Severe Asthma
  ClinicalTrials.gov Identifier: NCT00090740 - Recruiting
  Asthma
  
• Genetic Risk for Attention Deficit Hyperactivity Disorder Expressed in Brain Functioning
  ClinicalTrials.gov Identifier: NCT00143832 - Recruiting
  Attention Deficit Hyperactivity Disorder
  
• Genetic Studies in Alzheimer's Disease
  ClinicalTrials.gov Identifier: NCT00001235 - Completed
  Alzheimer's Disease; Nervous System Disease
  
• Genetic Studies in Difficult to Treat Asthma: TENOR
  ClinicalTrials.gov Identifier: NCT00091767 - Active, not recruiting
  Asthma; Lung Diseases
  
• Genetic Studies in Interstitial Cystitis
  ClinicalTrials.gov Identifier: NCT00389142 - Recruiting
  Interstitial Cystitis; Painful Bladder Syndrome; Hypersensitive Bladder Syndrome; Chronic Pelvic Pain Syndrome
  
• Genetic Studies in Liver Cancer Patients
  ClinicalTrials.gov Identifier: NCT00172640 - Recruiting
  Hepatocellular Carcinoma
  
• Genetic Studies in the Amish and Mennonites
  ClinicalTrials.gov Identifier: NCT00359580 - Recruiting
  Genetic Disease
  
• Genetic Studies of Chronic Active Epstein-Barr Disease
  ClinicalTrials.gov Identifier: NCT00032513 - Recruiting
  Epstein-Barr Virus Infections
  
• Genetic Studies of Inflammatory Bowel Disease
  ClinicalTrials.gov Identifier: NCT00340444 - Completed
  Inflammatory Bowel Disease
  
• Genetic Studies of Insulin and Diabetes
  ClinicalTrials.gov Identifier: NCT00001987 - Recruiting
  Diabetes Mellitus; Insulin Resistance
  
• Genetic Studies of Lupus
  ClinicalTrials.gov Identifier: NCT00071175 - Recruiting
  Systemic Lupus Erythematosus
  
• Genetic Studies of Lysosomal Storage Disorders
  ClinicalTrials.gov Identifier: NCT00001215 - Recruiting
  Gaucher's Disease; Lysosomal Storage Disease
  
• Genetic Studies of Psychiatric Illness
  ClinicalTrials.gov Identifier: NCT00252577 - Recruiting
  Bipolar Disorder
  
• Genetic Studies of Tone Deafness
  ClinicalTrials.gov Identifier: NCT00006076 - Recruiting
  Healthy; Tone Deafness
  
• Genetic Studies of X-Linked Lymphoproliferative Disease
  ClinicalTrials.gov Identifier: NCT00359411 - Recruiting
  X-Linked Lymphoproliferative Disease; Lymphoproliferative Disease; Genetic Diseases, X-Linked
  
• Genetic Studies Spermatogenic Failure
  ClinicalTrials.gov Identifier: NCT00548977 - Completed
  Oligospermia; Azoospermia; Male Infertility
  
• Genetic Studies to Identify Stroke Subtypes and Outcome
  ClinicalTrials.gov Identifier: NCT00357513 - Active, not recruiting
  Cerebrovascular Disease; Stroke
  
• Genetic Study in Patients Receiving Treatment for Hodgkin's Disease or Childhood Brain Tumor
  ClinicalTrials.gov Identifier: NCT00006342 - Active, not recruiting
  Lymphoma; Brain Tumor
  
• Genetic Study in Patients with Advanced Epithelial Ovarian Cancer
  ClinicalTrials.gov Identifier: NCT00053235 - Not yet recruiting
  stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
  
• Genetic Study in Patients With Stage II or Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00003833 - Completed
  stage II colon cancer; stage III colon cancer; adenocarcinoma of the colon
  
• Genetic Study of Age-Related Macular Degeneration
  ClinicalTrials.gov Identifier: NCT00357578 - Completed
  Age-Related Macular Degeneration
  
• Genetic Study of Atrial Fibrillation: Focusing on Renin-Angiotensin System and C-Reactive Protein Genes
  ClinicalTrials.gov Identifier: NCT00173030 - Recruiting
  Atrial Fibrillation
  
• Genetic Study of Brain Tumors in Young Children
  ClinicalTrials.gov Identifier: NCT00010101 - Completed
  childhood choroid plexus tumor; untreated childhood supratentorial primitive neuroectodermal tumors; untreated childhood medulloblastoma; ...
  
• Genetic Study of Cancer Risk and Gene Identification in Patients and Families With Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome
  ClinicalTrials.gov Identifier: NCT00055627 - Recruiting
  Cutaneous Leiomyoma; Kidney Cancer; Uterine Leiomyoma; Uterine Leiomyomata
  
• Genetic Study of Cancer Risk and Gene Identification in Patients With Inherited Bone Marrow Disorders and Their Families
  ClinicalTrials.gov Identifier: NCT00056121 - Recruiting
  Cancer
  
• Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma
  ClinicalTrials.gov Identifier: NCT00003793 - Active, not recruiting
  Ewing's family of tumors; childhood rhabdomyosarcoma; childhood soft tissue sarcoma; hematopoietic and lymphoid cancer; Osteosarcoma
  
• Genetic Study of Chronic Lymphocytic Leukemia Families
  ClinicalTrials.gov Identifier: NCT00503256 - Recruiting
  Leukemia
  
• Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
  ClinicalTrials.gov Identifier: NCT00499317 - Recruiting
  Chronic Prostatitis (CP); Chronic Pelvic Pain Syndrome (CPPS); Painful Bladder Syndrome (PBS); Benign Frequency Syndrome (BFS); Benign Daytime Frequency Syndrome (BDFS)
  
• Genetic Study of Familial Epilepsy
  ClinicalTrials.gov Identifier: NCT00006059 - Completed
  Epilepsy
  
• Genetic Study of Familial Factors in Patients With Colon Cancer
  ClinicalTrials.gov Identifier: NCT00055848 - Recruiting
  adenocarcinoma of the colon; stage I colon cancer; stage II colon cancer; stage III colon cancer; stage IV colon cancer
  
• Genetic Study of Insulin-Like Growth Factor-I Receptor Mutations in Patients With Intrauterine Growth Retardation
  ClinicalTrials.gov Identifier: NCT00005105 - Recruiting
  Intrauterine Growth Retardation
  
• Genetic Study of Late-Occurring Complications in Childhood Cancer Survivors
  ClinicalTrials.gov Identifier: NCT00082745 - Recruiting
  unspecified childhood solid tumor, protocol specific; long-term effects secondary to cancer therapy in children
  
• Genetic Study of Liver Enzymes in Patients With Side Effects From Antidepressants
  ClinicalTrials.gov Identifier: NCT00360256 - Recruiting
  Major Depressive Disorder
  
• Genetic Study of Lupus Patients and Their Families
  ClinicalTrials.gov Identifier: NCT00235378 - Recruiting
  Systemic Lupus Erythematosus
  
• Genetic Study of Nephrolitiasis in Gouty Diatesis
  ClinicalTrials.gov Identifier: NCT00149305 - Recruiting
  Gouty diatesis
  
• Genetic Study of Newly Diagnosed Central Nervous System Tumors in Young Children
  ClinicalTrials.gov Identifier: NCT00010114 - Completed
  childhood choroid plexus tumor; childhood central nervous system germ cell tumor; untreated childhood supratentorial primitive neuroectodermal tumors; ...
  
• Genetic Study of Patients and Families With a History of Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00003648 - Active, not recruiting
  Colon Cancer; Gastrointestinal Cancer; Rectal Cancer
  
• Genetic Study of Patients and Families With Birt-Hogg-Dube Syndrome
  ClinicalTrials.gov Identifier: NCT00039533 - Recruiting
  Birt Hogg Dube Syndrome; Kidney Cancer
  
• Genetic Study of Patients and Families With Diaphyseal Medullary Stenosis With Malignant Fibrous Histiocytoma of the Bone
  ClinicalTrials.gov Identifier: NCT00007046 - Completed
  Stenosis; Histiocytoma
  
• Genetic Study of Patients Previously Treated With Flavopiridol on Clinical Trial NCI-97-C-0171C
  ClinicalTrials.gov Identifier: NCT00040729 - Completed
  unspecified adult solid tumor, protocol specific
  
• Genetic Study of Patients Suffering From Congenital Amaurosis of Leber or From an Early Severe Retinal Dystrophy
  ClinicalTrials.gov Identifier: NCT00422721 - Not yet recruiting
  Amaurosis of Leber; Retinal Diseases
  
• Genetic Study of Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00048958 - Recruiting
  adult acute lymphoblastic leukemia; adult acute myeloid leukemia; childhood acute lymphoblastic leukemia; ...
  
• Genetic Study of Patients With Inherited Urologic Malignancies
  ClinicalTrials.gov Identifier: NCT00019617 - Recruiting
  Birt Hogg Dube Syndrome; Kidney Cancer; Multiple Endocrine Neoplasia 1 and 2 (men1, men2); Von Hippel-Lindau Syndrome
  
• Genetic Study of Patients With Primary Ciliary Dyskinesia
  ClinicalTrials.gov Identifier: NCT00005650 - Completed
  Primary Ciliary Dyskinesia
  
• Genetic Study of Patients With von Hippel-Lindau Syndrome
  ClinicalTrials.gov Identifier: NCT00003866 - Active, not recruiting
  childhood kidney/urinary cancer; Renal Cell Cancer
  
• Genetic Study of Schizophrenia
  ClinicalTrials.gov Identifier: NCT00001486 - Recruiting
  Psychotic Disorder; Schizoaffective Disorder; Schizophrenia
  
• Genetic Study of Sitosterolemia
  ClinicalTrials.gov Identifier: NCT00004481 - Completed
  Lipid Metabolism, Inborn Errors; Sitosterolemia
  
• Genetic Study of the FBN1 Gene and Fibrillin-1 Abnormalities in Choctaw Native Americans and Other Patients with Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00006393 - Recruiting
  Systemic Sclerosis
  
• Genetic Study of Young Patients With Colorectal Cancer
  ClinicalTrials.gov Identifier: NCT00044967 - Completed
  Colon Cancer; Rectal Cancer
  
• Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have von Hippel-Lindau Syndrome or Are at Risk for von Hippel-Lindau Syndrome
  ClinicalTrials.gov Identifier: NCT00075348 - Recruiting
  Renal Cell Cancer; von Hippel-Lindau Syndrome
  
• Genetic Substudy of the Alternans Before Cardioverter Defibrillator (ABCD) Trial
  ClinicalTrials.gov Identifier: NCT00583297 - Recruiting
  Coronary Artery Disease; Heart Failure; Ventricular Tachycardia
  
• Genetic Susceptibility in Migrant Farmworker Children
  ClinicalTrials.gov Identifier: NCT00501280 - Active, not recruiting
  Epidemiology
  
• Genetic Susceptibility or Resistance to Hepatitis B Virus in the Chinese Population
  ClinicalTrials.gov Identifier: NCT00565825 - Recruiting
  Liver Cancer; Precancerous/Nonmalignant Condition
  
• Genetic Susceptibility to Cardiovascular Disease in Patients on Kidney Dialysis
  ClinicalTrials.gov Identifier: NCT00340119 - Active, not recruiting
  End Stage Renal Disease; ESRD
  
• Genetic Susceptibility to Childhood Respiratory IIlness in Mexico City
  ClinicalTrials.gov Identifier: NCT00339521 - Active, not recruiting
  Asthma
  
• Genetic Susceptibility to Factor VIII Inhibitors
  ClinicalTrials.gov Identifier: NCT00344435 - Recruiting
  Hemophilia
  
• Genetic Susceptibility to Oncogenic Viruses
  ClinicalTrials.gov Identifier: NCT00341484 - Active, not recruiting
  Infection
  
• Genetic Susceptibility to Ozone in Mild Asthmatic Volunteers
  ClinicalTrials.gov Identifier: NCT00287365 - Recruiting
  Mild Asthma
  
• Genetic Testing in Detection of Late-Onset Hearing Loss
  ClinicalTrials.gov Identifier: NCT00511381 - Recruiting
  Hearing Loss; Late-Onset Hearing Loss; Deafness
  
• Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer
  ClinicalTrials.gov Identifier: NCT00088829 - Recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer; stage IV breast cancer
  
• Genetic Testing or Clinical Assessment in Determining the Need for Chemotherapy in Women With Node-Negative Breast Cancer
  ClinicalTrials.gov Identifier: NCT00433589 - Recruiting
  Breast Cancer
  
• Genetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or Lymphoma
  ClinicalTrials.gov Identifier: NCT00003970 - Completed
  adult solid tumor; Leukemia; Lymphoma; small intestine cancer
  
• Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
  ClinicalTrials.gov Identifier: NCT00048971 - Completed
  adenocarcinoma of the colon; stage III colon cancer; Diarrhea; Neutropenia
  
• Genetic Variation and Immune Responses After Injury
  ClinicalTrials.gov Identifier: NCT00294697 - Recruiting
  Sepsis; Pneumonia; Trauma; Burn; Injury
  
• Genetic Variation – The Need for Opioids During Surgery
  ClinicalTrials.gov Identifier: NCT00327938 - Completed
  Pain
  
• Genetic- and Biological-Markers of Predisposition to Atherosclerosis: Leipzig-Heart Study
  ClinicalTrials.gov Identifier: NCT00497887 - Recruiting
  Atherosclerosis; Coronary Arteriosclerosis; Carotid Artery Diseases; Genetic Predisposition to Disease; Biological Markers
  
• Genetically Modified Lymphocytes to Treat HIV-infected Identical Twins - Study Modifications
  ClinicalTrials.gov Identifier: NCT00001409 - Completed
  Acquired Immunodeficiency Syndrome; HIV Infection
  
• Genetics and Cardiovascular Reactivity in Young Twins
  ClinicalTrials.gov Identifier: NCT00083850 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Genetics and Clinical Characteristics of Bardet-Biedl Syndrome
  ClinicalTrials.gov Identifier: NCT00078091 - Recruiting
  Bardet-Biedl Syndrome
  
• Genetics and Psychopathology in the 22q11 Deletion Syndrome
  ClinicalTrials.gov Identifier: NCT00161109 - Recruiting
  The 22q11.2 deletion syndrome.; Psychiatric symptoms; Neuropsychological impairments; Psychophysiological performance
  
• Genetics Education: Preparing Physicians for the Future
  ClinicalTrials.gov Identifier: NCT00349817 - Recruiting
  Primary Care Genetics; Hereditary Colorectal Cancer
  
• Genetics of Aging-Associated Conditions in Sardinia
  ClinicalTrials.gov Identifier: NCT00182949 - Recruiting
  Aging; Cardiovascular Disease
  
• Genetics of Airway Responsiveness and Lung Function
  ClinicalTrials.gov Identifier: NCT00005537 - Completed
  Asthma; Lung Diseases, Obstructive; Chronic Obstructive Pulmonary Disease
  
• Genetics of Alpha Thalassemia in Israeli Ethnic Groups
  ClinicalTrials.gov Identifier: NCT00159029 - Recruiting
  alpha Thalassemia
  
• Genetics of Ankylosing Spondylitis
  ClinicalTrials.gov Identifier: NCT00081562 - Active, not recruiting
  Spondylitis; Ankylosing Spondylitis
  
• Genetics of Asthma and Bronchial Hyperresponsiveness
  ClinicalTrials.gov Identifier: NCT00005359 - Active, not recruiting
  Asthma; Lung Diseases
  
• Genetics of Atherosclerosis in Mexican Americans
  ClinicalTrials.gov Identifier: NCT00005462 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Obesity; Atherosclerosis; Diabetes Mellitus, non-insulin dependent; Diabetes Mellitus
  
• Genetics of Cardiovascular and Neuromuscular Disease
  ClinicalTrials.gov Identifier: NCT00138931 - Recruiting
  Cardiomyopathy; Arrhythmia; Muscular Dystrophy
  
• Genetics of Cardiovascular Reactivity in Black Youth
  ClinicalTrials.gov Identifier: NCT00064675 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Genetics of Coronary Artery Disease in Alaskan Natives (GOCODAN)
  ClinicalTrials.gov Identifier: NCT00006192 - Active, not recruiting
  Heart Diseases; Cardiovascular Diseases; Atherosclerosis; Hypertension; Diabetes Mellitus; Coronary Arteriosclerosis
  
• Genetics of CRP in Families with Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00064519 - Active, not recruiting
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Myocardial Infarction
  
• Genetics of CVD Risk Factors in Samoans
  ClinicalTrials.gov Identifier: NCT00005528 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity; Atherosclerosis
  
• Genetics of Endocrine Tumours
  ClinicalTrials.gov Identifier: NCT00461188 - Recruiting
  Acromegaly
  
• Genetics of Familial Testicular Cancer
  ClinicalTrials.gov Identifier: NCT00342537 - Recruiting
  Testicular Cancer
  
• Genetics of Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00071162 - Active, not recruiting
  Fibromyalgia; Irritable Bowel Syndrome; Chronic Fatigue Syndrome; Depression
  
• Genetics of Hepatitis C Virus Infection
  ClinicalTrials.gov Identifier: NCT00005657 - Recruiting
  Hepatitis C; Liver Disease
  
• Genetics of Hypertension and Its Intermediate Phenotypes
  ClinicalTrials.gov Identifier: NCT00006499 - Completed
  Cardiovascular Diseases; Hypertension
  
• Genetics of Hypertension in Blacks
  ClinicalTrials.gov Identifier: NCT00005387 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension
  
• Genetics of Interstitial Cystitis
  ClinicalTrials.gov Identifier: NCT00237081 - Recruiting
  Interstitial Cystitis; Painful Bladder Syndrome
  
• Genetics of Low Density Lipoprotein Subclasses in Hypercholesterolemia
  ClinicalTrials.gov Identifier: NCT00005203 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypercholesterolemia
  
• Genetics of Middle Ear Disease
  ClinicalTrials.gov Identifier: NCT00422136 - Active, not recruiting
  Otitis Media
  
• Genetics of Obsessive-Compulsive Disorder
  ClinicalTrials.gov Identifier: NCT00001548 - Recruiting
  Obsessive Compulsive Disorder
  
• Genetics of Progressive Multifocal Leukoencephalopathy and Acquired Immunodeficiency Syndrome
  ClinicalTrials.gov Identifier: NCT00342602 - Recruiting
  PML; AIDS
  
• Genetics of Recurrent Early Onset Major Depression
  ClinicalTrials.gov Identifier: NCT00260182 - Recruiting
  Depression
  
• Genetics of Recurrent Early-Onset Depression
  ClinicalTrials.gov Identifier: NCT00005914 - Completed
  Depression
  
• Genetics of Response to Clozapine and Other Antipsychotic Drugs and Vulnerability to Hallucinations
  ClinicalTrials.gov Identifier: NCT00178932 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Bipolar Disorder; Major Depression
  
• Genetics of Rheumatoid Arthritis
  ClinicalTrials.gov Identifier: NCT00001678 - Active, not recruiting
  Rheumatoid Arthritis
  
• Genetics of Rolandic Epilepsy
  ClinicalTrials.gov Identifier: NCT00282854 - Recruiting
  Epilepsy
  
• Genetics of Spina Bifida
  ClinicalTrials.gov Identifier: NCT00031122 - Recruiting
  Spina Bifida
  
• Genetics of the Metabolic Syndrome in Japanese Americans
  ClinicalTrials.gov Identifier: NCT00005374 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases; Insulin Resistance; Diabetes Mellitus, non-insulin dependent; Diabetes Mellitus; ...
  
• Genetics of Wilms' Tumor and/or the Associated Conditions of Aniridia, Hemihypertrophy, and Genitourinary Anomalies
  ClinicalTrials.gov Identifier: NCT00503893 - Recruiting
  Wilms' Tumor; Aniridia
  
• Genetics of Women With Lobular Carcinoma in Situ of the Breast
  ClinicalTrials.gov Identifier: NCT00536718 - Recruiting
  Breast Cancer
  
• Genetics, Metabolism and Weight Loss in Older, Obese Veterans
  ClinicalTrials.gov Identifier: NCT00018330 - Completed
  Obesity
  
• GenetiKiT: Evaluation of an Educational Intervention on the Delivery of Genetics Services by Family Physicians
  ClinicalTrials.gov Identifier: NCT00295529 - Active, not recruiting
  Breast Neoplasm
  
• GenHAT--Genetics of Hypertension Associated Treatments
  ClinicalTrials.gov Identifier: NCT00006294 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Hypertension; Coronary Disease; Myocardial Infarction
  
• Genistein and Endometrial Hyperplasia
  ClinicalTrials.gov Identifier: NCT00453960 - Recruiting
  Endometrial Hyperplasia
  
• Genistein and Interleukin-2 in Treating Patients With Metastatic Melanoma or Kidney Cancer
  ClinicalTrials.gov Identifier: NCT00276835 - Recruiting
  Kidney Cancer; Melanoma (Skin)
  
• Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00290758 - Recruiting
  Breast Cancer
  
• Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women
  ClinicalTrials.gov Identifier: NCT00099008 - Completed
  Breast Cancer; Endometrial Cancer
  
• Genistein in Treating Patients Who Are Undergoing Surgery for Bladder Cancer
  ClinicalTrials.gov Identifier: NCT00118040 - Suspended
  stage 0 bladder cancer; recurrent bladder cancer; stage I bladder cancer; stage II bladder cancer; stage III bladder cancer; stage IV bladder cancer
  
• Genistein in Treating Patients With Localized Prostate Cancer Who Are Planning to Undergo Radical Prostatectomy
  ClinicalTrials.gov Identifier: NCT00058266 - Suspended
  stage I prostate cancer; stage II prostate cancer
  
• Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00005827 - Completed
  stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer; adenocarcinoma of the prostate; recurrent prostate cancer
  
• Genistein, Gemcitabine, and Erlotinib in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00376948 - Suspended
  Pancreatic Cancer
  
• Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
  ClinicalTrials.gov Identifier: NCT00339963 - Recruiting
  Lymphoma; Leukemia; Multiple Myeloma; Lymphoid Malignancies
  
• Genome Scan for Obesity in a Multi-Ethnic Sample
  ClinicalTrials.gov Identifier: NCT00037271 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• Genome-Guided Adjuvant Cisplatin With Either Vinorelbine or Pemetrexed for Early Stage Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00545948 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• Genomewide Screening of Pathological Myopia
  ClinicalTrials.gov Identifier: NCT00155753 - Recruiting
  pathological myopia
  
• Genomewide Search for Loci Underlying Metabolic Syndrome
  ClinicalTrials.gov Identifier: NCT00074451 - Active, not recruiting
  Metabolic Syndrome X; Cardiovascular Diseases; Heart Diseases; Obesity; Hypertension; Hyperinsulinism; Insulin Resistance
  
• Genomic & Proteomic Analysis of Docetaxel & Capecitabine as Primary Chemo for Stage II-III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00198237 - Completed
  Breast Cancer
  
• Genomic and Proteomic Analysis of Disease Progression in IPF
  ClinicalTrials.gov Identifier: NCT00373841 - Recruiting
  Pulmonary Fibrosis
  
• Genomic Dissection of a QTL Affecting the Lipid Profile
  ClinicalTrials.gov Identifier: NCT00064688 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Obesity; Hyperlipidemia, Familial Combined
  
• Genomic Endometrial Expression in Obesity
  ClinicalTrials.gov Identifier: NCT00505986 - Recruiting
  Obesity and Embryo Implantation
  
• Genomic Search for Childhood Obesity Genes-A Pilot Study
  ClinicalTrials.gov Identifier: NCT00484172 - Not yet recruiting
  Obesity
  
• Genomic Tools for Studying the Ecology of the Human Vaginal Microflora
  ClinicalTrials.gov Identifier: NCT00576797 - Recruiting
  To Determine the Normal Bacteria in the Vagina
  
• Genomics and Postoperative Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00280163 - Recruiting
  Postoperative Atrial Fibrillation, Genomics
  
• Genomics of In-Stent Restenosis
  ClinicalTrials.gov Identifier: NCT00341562 - Completed
  In-Stent Restenosis; Vascular Disease
  
• Genomics, SNPs, and Clinical Neonatology
  ClinicalTrials.gov Identifier: NCT00315263 - Recruiting
  Chronic Lung Disease; Periventricular Brain Injury; Necrotizing Enterocolitis; Hypoxic Respiratory Failure
  
• Genotoxicity Assessment for Patients Undergoing Radiation Treatment
  ClinicalTrials.gov Identifier: NCT00167427 - Recruiting
  Neoplasms
  
• Genotype - Phenotype Correlations of LINCL
  ClinicalTrials.gov Identifier: NCT00151268 - Recruiting
  Batten Disease; Late Infantile Neuronal Lipofuscinosis
  
• Genotype Influence on Recovery After Traumatic Brain Injury
  ClinicalTrials.gov Identifier: NCT00018499 - Completed
  Brain Injury
  
• Genotype/Phenotype Correlation of Movement Disorders and Other Neurological Diseases
  ClinicalTrials.gov Identifier: NCT00001667 - Completed
  Movement Disorders; Myoclonus; Nervous System Diseases; Tic Disorders; Tremor
  
• Genotyping Directed Salvage Therapy in Children Who Have Failed Dual NRTIs
  ClinicalTrials.gov Identifier: NCT00477308 - Active, not recruiting
  HIV Infections
  
• Genotyping of Cytomegalovirus From Patients in Israel
  ClinicalTrials.gov Identifier: NCT00228202 - Recruiting
  Cytomegalovirus Infections
  
• Gentamicin Treatment of Muscular Dystrophy
  ClinicalTrials.gov Identifier: NCT00005574 - Completed
  Becker muscular dystrophy; Duchenne muscular dystrophy
  
• Geodon (Ziprasidone) for Posttraumatic Stress Disorder
  ClinicalTrials.gov Identifier: NCT00208208 - Completed
  Posttraumatic Stress Disorder; Post-Traumatic Stress Disorder; PTSD
  
• Geodon in Social Anxiety Disorder
  ClinicalTrials.gov Identifier: NCT00215150 - Recruiting
  Social Anxiety Disorder
  
• Geodon in Weight Loss Study for Bipolar Disorders
  ClinicalTrials.gov Identifier: NCT00472641 - Recruiting
  Bipolar Disorder
  
• Geographic Modeling of Traffic and Asthma Rates
  ClinicalTrials.gov Identifier: NCT00041834 - Completed
  Asthma
  
• Gepirone vs Placebo in Treatment of Cocaine Dependence - 3
  ClinicalTrials.gov Identifier: NCT00000189 - Completed
  Cocaine-Related Disorders
  
• GER-009-06-AVX Early Therapy in Multiple Sclerosis
  ClinicalTrials.gov Identifier: NCT00492570 - Active, not recruiting
  Relapsing-Remitting Multiple Sclerosis
  
• Geriatric Education and Its Effect on Certain Aspects of Hospital Care of Nursing Home Patients
  ClinicalTrials.gov Identifier: NCT00384709 - Not yet recruiting
  Frail Elderly; Patient Care
  
• German Adrenocortical Carcinoma Registry
  ClinicalTrials.gov Identifier: NCT00453674 - Recruiting
  Adrenocortical Carcinoma
  
• German Corneal Cross Linking Register
  ClinicalTrials.gov Identifier: NCT00560651 - Recruiting
  Keratoconus; Corneal Cross Linking
  
• German Multicenter Trial for the Treatment of Newly Diagnosed T-Lymphoblastic Lymphoma in Adults
  ClinicalTrials.gov Identifier: NCT00199017 - Recruiting
  Lymphoma, Lymphoblastic
  
• German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00198978 - Recruiting
  Adult Acute Lymphocytic Leukemia
  
• German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)
  ClinicalTrials.gov Identifier: NCT00199069 - Completed
  Adult Acute Lymphocytic Leukemia
  
• German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99)
  ClinicalTrials.gov Identifier: NCT00199056 - Completed
  Adult Acute Lymphocytic Leukemia
  
• German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003)
  ClinicalTrials.gov Identifier: NCT00198991 - Recruiting
  Adult Acute Lymphocytic Leukemia
  
• German Preoperative Adriamycin Docetaxel Study
  ClinicalTrials.gov Identifier: NCT00543829 - Completed
  Breast Neoplasms
  
• Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients
  ClinicalTrials.gov Identifier: NCT00579514 - Recruiting
  Breast Cancer; Colon Cancer; Prostate Cancer
  
• Germline Mutations in Patients With Head and Neck Cancer and a Family History of Cancer
  ClinicalTrials.gov Identifier: NCT00482872 - Recruiting
  Head and Neck Cancer
  
• Gestational Diabetes Mellitus Trial
  ClinicalTrials.gov Identifier: NCT00069576 - Recruiting
  Diabetes, Gestational
  
• GF-GS 01
  ClinicalTrials.gov Identifier: NCT00144898 - Recruiting
  Breast cancer unifocal N0
  
• GFR Reporting on Nephrology Referral Patterns by Internists
  ClinicalTrials.gov Identifier: NCT00134797 - Recruiting
  Chronic Kidney Disease
  
• GH, IGF-I and Somatostatin Analogues in Hepatocellular Carcinoma
  ClinicalTrials.gov Identifier: NCT00495846 - Recruiting
  Advanced Hepatocellular Carcinoma
  
• GHB: Effects, Withdrawal and Treatment - 1
  ClinicalTrials.gov Identifier: NCT00123578 - Recruiting
  
  
• Ghrelin Decreases Insulin Sensitivity
  ClinicalTrials.gov Identifier: NCT00512525 - Completed
  Insulin Sensitivity; Liposysis
  
• Ghrelin in Older Women
  ClinicalTrials.gov Identifier: NCT00520884 - Recruiting
  Frailty
  
• Ghrelin Levels in Early IVF Pregnancies
  ClinicalTrials.gov Identifier: NCT00469807 - Completed
  Pregnancy
  
• Ghrelin Levels in Pancreatic Cancer Patients
  ClinicalTrials.gov Identifier: NCT00225745 - Recruiting
  Pancreactic Cancer
  
• Ghrelin, GH and Cortisol Interaction in GHD Patients
  ClinicalTrials.gov Identifier: NCT00139945 - Active, not recruiting
  Hypopituitarism
  
• GI Interlab 2 Study: Measuring the Glycaemic Index (GI) of Foods
  ClinicalTrials.gov Identifier: NCT00260858 - Completed
  Healthy
  
• GI Reflux in Lung Transplant and Its Relationship to Chronic Rejection
  ClinicalTrials.gov Identifier: NCT00455078 - Recruiting
  Gastroesophageal Reflux
  
• GI-270384 Study In Patients With Mild To Moderate Ulcerative Colitis
  ClinicalTrials.gov Identifier: NCT00457171 - Terminated
  Ulcerative Colitis
  
• GI-Reasons- A Trial Of GI Safety Of Celecoxib Compared With Non-Selective Nonsteroidal Antiinflammatory Drugs (Nsaids) I
  ClinicalTrials.gov Identifier: NCT00373685 - Recruiting
  Osteoarthritis
  
• GIANT: General Practitioner Implementation in Asia of Normoglycaemic Targets
  ClinicalTrials.gov Identifier: NCT00499824 - Recruiting
  Type 2 Diabetes Mellitus
  
• GILT Docetaxel - Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00174629 - Active, not recruiting
  Lung Neoplasms
  
• Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma
  ClinicalTrials.gov Identifier: NCT00087061 - Completed
  adult anaplastic oligodendroglioma; recurrent adult brain tumor; adult glioblastoma; adult anaplastic astrocytoma; adult giant cell glioblastoma; ...
  
• GIMEMA LAL 0496: High-Dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL.
  ClinicalTrials.gov Identifier: NCT00439920 - Completed
  Acute Lymphoblastic Leukemia
  
• Ginger Control of Chemotherapy Induced Nausea and Vomiting
  ClinicalTrials.gov Identifier: NCT00065221 - Recruiting
  Nausea; Vomiting; Chemotherapy
  
• Ginger in Treating Nausea and Vomiting in Patients Receiving Chemotherapy for Cancer
  ClinicalTrials.gov Identifier: NCT00064272 - Completed
  nausea and vomiting; unspecified adult solid tumor, protocol specific
  
• Ginger in Treating Nausea in Patients Receiving Chemotherapy for Cancer
  ClinicalTrials.gov Identifier: NCT00040742 - Recruiting
  nausea and vomiting; unspecified adult solid tumor, protocol specific
  
• GINGER: Insulin Glulisine in Diabetes Mellitus, Type 2
  ClinicalTrials.gov Identifier: NCT00174668 - Active, not recruiting
  Diabetes Mellitus, Type 2
  
• Ginkgo Biloba Extract and the Insulin Resistance Syndrome
  ClinicalTrials.gov Identifier: NCT00032474 - Completed
  Type 2 diabetes mellitus
  
• Ginkgo Biloba Prevention Trial in Older Individuals
  ClinicalTrials.gov Identifier: NCT00010803 - Active, not recruiting
  Dementia; Alzheimer's Disease
  
• Ginkgo Biloba to Improve Short-Term Memory Losses Associated With Electroconvulsive Therapy (ECT)
  ClinicalTrials.gov Identifier: NCT00070954 - Recruiting
  Memory, Short-Term
  
• Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction
  ClinicalTrials.gov Identifier: NCT00034021 - Completed
  Hypoactive Sexual Desire Disorder; Sexual Dysfunctions, Psychological
  
• GIP: Glucose-Dependent Insulinotropic Peptide
  ClinicalTrials.gov Identifier: NCT00239707 - Active, not recruiting
  Type 2 Diabetes
  
• Girls Health Enrichment Multi-Site Studies (GEMS)
  ClinicalTrials.gov Identifier: NCT00000615 - Completed
  Cardiovascular Diseases; Heart Diseases; Obesity
  
• GISSI-AF - Use of Valsartan an Angiotensin II AT1-Receptor Blocker in the Prevention of Atrial Fibrillation Recurrence
  ClinicalTrials.gov Identifier: NCT00376272 - Active, not recruiting
  Atrial Fibrillation
  
• GISSI-HF- Effects of n-3 PUFA and Rosuvastatin on Mortality-Morbidity of Patients With Symptomatic CHF
  ClinicalTrials.gov Identifier: NCT00336336 - Active, not recruiting
  Heart Failure
  
• GISSOC II: Sirolimus Eluting Stent Versus Bare Metal Stent in Chronic Total Coronary Occlusions
  ClinicalTrials.gov Identifier: NCT00220558 - Recruiting
  Coronary Artery Disease
  
• GIST in the Region de Coquimbo
  ClinicalTrials.gov Identifier: NCT00564265 - Not yet recruiting
  Gastrointestinal Stromal Tumors
  
• Giving Epstein-Barr Virus (EBV) Specific Killer T Lymphocytes to Patients who have had Donor Marrow Grafts.
  ClinicalTrials.gov Identifier: NCT00058812 - Recruiting
  Bone Marrow Transplantation; Epstein-Barr Virus Infections
  
• Giving Gene Marked (Optional) Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells to Patients with Relapsed EBV-Positive Lymphoma,
  ClinicalTrials.gov Identifier: NCT00058617 - Recruiting
  Hodgkins Disease; Non-Hodgkins Lymphoma
  
• Giving Gene Marked Epstein Barr Virus (EBV) Specific T-Cells to Patients Receiving a Bone Marrow Transplant (BMT) for Relapsed EBV-Positive Hodgkin Disease
  ClinicalTrials.gov Identifier: NCT00058773 - Completed
  Hodgkin Disease; Non-Hodgkins Lymphoma
  
• GL701 (Prestara™) in Women with Systemic Lupus Erythematosus Receiving Treatment with Glucocorticoids
  ClinicalTrials.gov Identifier: NCT00082511 - Active, not recruiting
  Systemic Lupus Erythematosus
  
• GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00280865 - Completed
  Type 2 Diabetes
  
• Glaser Obesity Study
  ClinicalTrials.gov Identifier: NCT00209482 - Active, not recruiting
  Obesity
  
• Glaucoma Laser Trial (GLT) Glaucoma Laser Trial Followup Study (GLTFS)
  ClinicalTrials.gov Identifier: NCT00000144 - Completed
  Open-Angle Glaucoma
  
• Gleevec & Docetaxel Study in Head and Neck Squamous Cell Cancer Patients
  ClinicalTrials.gov Identifier: NCT00485485 - Recruiting
  Head and Neck Squamous Cell Cancer; Head and Neck
  
• Gleevec Administered Preoperatively to Reduce Gastrointestinal Stromal Tumor (GIST)
  ClinicalTrials.gov Identifier: NCT00290485 - Recruiting
  Gastrointestinal Stromal Tumors
  
• Gleevec Combined With Camptosar Plus Paraplatin in Previously Untreated Extensive Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00193349 - Active, not recruiting
  Lung Cancer
  
• Gleevec Idiopathic Pulmonary Fibrosis (IPF) Study
  ClinicalTrials.gov Identifier: NCT00131274 - Completed
  Idiopathic Pulmonary Fibrosis; Lung Disease; Pulmonary Fibrosis
  
• Gleevec in the Treatment of Systemic Sclerosis
  ClinicalTrials.gov Identifier: NCT00555581 - Recruiting
  Systemic Sclerosis
  
• Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients with C-Kit Positive Extensive SCLC
  ClinicalTrials.gov Identifier: NCT00156286 - Terminated
  Small Cell Lung Cancer
  
• Gleevec Trial in Patients with Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00081926 - Active, not recruiting
  Chronic Myelogenous Leukemia
  
• Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic Syndromes
  ClinicalTrials.gov Identifier: NCT00451997 - Completed
  Leukemia, Myeloid; Myelodysplastic Syndromes
  
• Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma
  ClinicalTrials.gov Identifier: NCT00506779 - Recruiting
  Uterine Cancer
  
• Gliadel Wafer and O6-Benzylguanine in Treating Patients With Recurrent Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00362921 - Recruiting
  Brain and Central Nervous System Tumors
  
• Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM
  ClinicalTrials.gov Identifier: NCT00548938 - Recruiting
  Glioblastoma Multiforme; High-Grade Glioma
  
• Gliadel Wafers and Temodar in the Treatment of Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00574964 - Recruiting
  Primary Glioblastoma Multiforme
  
• Glimepiride Vs Metformin as Monotherapy in Pediatric Subjects With Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00353691 - Completed
  Type 2 Diabetes Mellitus
  
• Gliogene: Brain Tumor Linkage Study
  ClinicalTrials.gov Identifier: NCT00418899 - Recruiting
  Brain Tumor; Glioma
  
• Glitazones and Endothelial Function (GATE)
  ClinicalTrials.gov Identifier: NCT00203632 - Terminated
  Diabetes Mellitus
  
• Glivec in Ph Positive Lymphoblastic Leukemia
  ClinicalTrials.gov Identifier: NCT00388895 - Active, not recruiting
  Acute Lymphoblastic Leukemia; Cromosome Philadelphia Positive
  
• Glivec Phase II Pediatric Study
  ClinicalTrials.gov Identifier: NCT00180830 - Terminated
  Cancer
  
• Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid Leukaemia
  ClinicalTrials.gov Identifier: NCT00390897 - Active, not recruiting
  Chronic Myeloid Leukaemia
  
• Global Efficacy Study of MPC-7869 to Treat Patients With Alzheimer's
  ClinicalTrials.gov Identifier: NCT00322036 - Active, not recruiting
  Alzheimer Disease; Dementia
  
• GlObal Secondary Prevention strategiEs to Limit Event Recurrence After Myocardial Infarction. GOSPEL Study
  ClinicalTrials.gov Identifier: NCT00421876 - Completed
  Myocardial Infarction
  
• Global Tobacco Use Survey
  ClinicalTrials.gov Identifier: NCT00121368 - Completed
  Smoking
  
• Glomerular Injury of Preeclampsia
  ClinicalTrials.gov Identifier: NCT00275158 - Completed
  Pre-Eclampsia
  
• GLP-1 Infusion and Long-Time Fasting
  ClinicalTrials.gov Identifier: NCT00285896 - Active, not recruiting
  Type 2 Diabetes
  
• GLP-2 (Glucagonlike Peptide-2) and Blood Flow
  ClinicalTrials.gov Identifier: NCT00540215 - Active, not recruiting
  Regional Blood Flow
  
• Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers
  ClinicalTrials.gov Identifier: NCT00434772 - Not yet recruiting
  Hypoglycemia
  
• Glucagon Like Peptides Receptors Expression in the Stomach of Diabetes Type 2
  ClinicalTrials.gov Identifier: NCT00473733 - Not yet recruiting
  Diabetes Mellitus Type 2
  
• Glucocorticoid Effects on Cellular Cytokine Release
  ClinicalTrials.gov Identifier: NCT00001415 - Completed
  Depressive Disorder; Fatigue Syndrome, Chronic; Fibromyalgia; Healthy; Inflammation
  
• Glucocorticoid-Induced Osteopenia in Children
  ClinicalTrials.gov Identifier: NCT00289328 - Active, not recruiting
  Crohn's Disease; Nephrotic Syndrome
  
• Glucocorticoids Promote Osteoclast Survival
  ClinicalTrials.gov Identifier: NCT00572299 - Recruiting
  Postmenopausal Osteoporosis; Male Osteoporosis
  
• Glucolipotoxicity and Cardiac Dysfunction in Obesity
  ClinicalTrials.gov Identifier: NCT00178633 - Active, not recruiting
  Obesity; Diabetes,; Heart Failure,; Insulin Resistance
  
• Gluconeogenesis in Very Low Birth Weight Infants Who Are Receiving Nutrition By Intravenous Infusion
  ClinicalTrials.gov Identifier: NCT00005889 - Recruiting
  Infant, Low Birth Weight; Hyperglycemia
  
• Glucontrol Study: Comparing the Effects of Two Glucose Control Regimens by Insulin in Intensive Care Unit Patients
  ClinicalTrials.gov Identifier: NCT00107601 - Completed
  Critical Illness
  
• Glucosamine Sulphate and Increased Level of Blood Cholesterol
  ClinicalTrials.gov Identifier: NCT00251069 - Completed
  Osteoarthritis
  
• Glucosamine Sulphate, Ginger, Ginger-Avocado-Soya and Ginger-Ibuprofen for Chronic Back Pain
  ClinicalTrials.gov Identifier: NCT00317655 - Completed
  Back Pain
  
• Glucosamine Unum In Die [Once A Day] Efficacy (GUIDE) Trial: Glucosamine Sulfate in Patients with Knee Osteoarthritis
  ClinicalTrials.gov Identifier: NCT00110474 - Completed
  Knee Osteoarthritis
  
• Glucosamine/Chondroitin Arthritis Intervention Trial (GAIT)
  ClinicalTrials.gov Identifier: NCT00032890 - Completed
  Osteoarthritis
  
• Glucose and Lipid Metabolism on Antipsychotic Medication
  ClinicalTrials.gov Identifier: NCT00515723 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Type 2 Diabetes Mellitus; Hyperglycemia
  
• Glucose Control by eMPC Algorithm in Peri- and Postoperative Period in Cardiac Surgery Patients
  ClinicalTrials.gov Identifier: NCT00444171 - Completed
  Cardiac Surgery Patients; Blood Glucose
  
• Glucose Control In Hematopoetic Stem Cell Transplant
  ClinicalTrials.gov Identifier: NCT00582036 - Recruiting
  Hyperglycemia; Hematopoietic Stem Cell Transplantation
  
• Glucose Control in Open Heart Surgery
  ClinicalTrials.gov Identifier: NCT00370643 - Completed
  Hyperglycaemia During Perioperative Period; Heart Valve Diseases; Ventricular Dysfunction
  
• Glucose Control With Multiple Daily Insulin Injections In Diabetic Patients Hospitalized In A General Medicine Ward
  ClinicalTrials.gov Identifier: NCT00464854 - Terminated
  Diabetes Mellitus
  
• Glucose in Dialysis Water in Diabetics With Chronic Renal Failure
  ClinicalTrials.gov Identifier: NCT00438503 - Completed
  Renal Failure, Chronic; Diabetic Nephropathies
  
• Glucose in Dialysis Water in Non-Diabetics
  ClinicalTrials.gov Identifier: NCT00439023 - Completed
  Renal Failure, Chronic
  
• Glucose Metabolism Following Bariatric Surgery
  ClinicalTrials.gov Identifier: NCT00554593 - Recruiting
  Diabetes; Bariatric Surgery
  
• Glucose Metabolism in Patients With Non-Small Cell Lung Cancer Treated With Targeted Therapy and Chemotherapy
  ClinicalTrials.gov Identifier: NCT00450567 - Recruiting
  Lung Cancer
  
• Glucose Metabolism in the Immediate and Short Term Follow up After Bariatric Surgery
  ClinicalTrials.gov Identifier: NCT00488423 - Recruiting
  Diabetes; Gastric Bypass
  
• Glucose Optimisation With Angiotensin II Antagonist Losartan (GOAAL)
  ClinicalTrials.gov Identifier: NCT00237588 - Completed
  Hypertension
  
• Glucose regulation during risperidone and olanzapine treatment
  ClinicalTrials.gov Identifier: NCT00006195 - Recruiting
  Schizophrenia
  
• Glucose Regulation in Acute Stroke Patients (GRASP) Study
  ClinicalTrials.gov Identifier: NCT00282867 - Recruiting
  Stroke; Hyperglycemia
  
• Glucose/Insulin Responses:Subjects With Type 2 Diabetes Consuming Diabetes-Specific vs Standard Nutritional Formulas
  ClinicalTrials.gov Identifier: NCT00540488 - Completed
  Diabetes Mellitus Type 2
  
• Glufosfamide in Treating Patients With Recurrent Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00014300 - Active, not recruiting
  recurrent adult brain tumor; adult glioblastoma multiforme
  
• Glufosfamide With of Without Hydration in Treating Patients With Advanced Non-small cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00005055 - Active, not recruiting
  stage IIIA non-small cell lung cancer; stage IV non-small cell lung cancer; stage IIIB non-small cell lung cancer; ...
  
• Glufosfamide With or Without Hydration in Treating Patients With Advanced Pancreatic Cancer
  ClinicalTrials.gov Identifier: NCT00005053 - Active, not recruiting
  recurrent pancreatic cancer; stage IVA pancreatic cancer; stage III pancreatic cancer; stage IVB pancreatic cancer; adenocarcinoma of the pancreas
  
• Glulisine + Lantus in Type I Patients
  ClinicalTrials.gov Identifier: NCT00546702 - Completed
  Diabetes Mellitus, Type 1
  
• Glulisine Pre- and Postmeal
  ClinicalTrials.gov Identifier: NCT00290043 - Completed
  Diabetes Mellitus Type 1
  
• Glulysine + Lantus in Type I Patients
  ClinicalTrials.gov Identifier: NCT00545337 - Completed
  Diabetes Mellitus, Type 1
  
• Glutamate for Metabolic Intervention in Coronary Surgery
  ClinicalTrials.gov Identifier: NCT00489827 - Recruiting
  Coronary Artery Bypass; Myocardial Ischemia; Myocardial Infarction; Coronary Artery Disease
  
• Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients Receiving Vincristine for Wilms' Tumor, Rhabdomyosarcoma, Acute Lymphoblastic Leukemia, or Non-Hodgkin's Lymphoma
  ClinicalTrials.gov Identifier: NCT00369564 - Recruiting
  Kidney Cancer; Leukemia; Lymphoma; Neurotoxicity; Sarcoma
  
• Glutamine and Intestinal Protein Metabolism
  ClinicalTrials.gov Identifier: NCT00213551 - Recruiting
  Healthy Volunteers
  
• Glutamine Enriched Total Parenteral Feeding and Proline Metabolism in Severely Burned Patients
  ClinicalTrials.gov Identifier: NCT00217035 - Recruiting
  Burn Injury
  
• Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
  ClinicalTrials.gov Identifier: NCT00003170 - Active, not recruiting
  Pancreatic Cancer; Vulvar Cancer; Renal Cell Cancer; Endometrial Cancer; Testicular Cancer; ovarian epithelial cancer; Colon Cancer; Rectal Cancer; ...
  
• Glutamine in Preventing Myalgia and/or Arthralgia in Patients Who Are Receiving Paclitaxel For Cancer
  ClinicalTrials.gov Identifier: NCT00217724 - Active, not recruiting
  Pain; Unspecified Adult Solid Tumor, Protocol Specific
  
• Glutamine in Preventing Oral Mucositis in Patients Receiving Chemotherapy for Sarcoma
  ClinicalTrials.gov Identifier: NCT00334984 - Not yet recruiting
  Childhood Malignant Fibrous Histiocytoma of Bone; Sarcoma
  
• Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
  ClinicalTrials.gov Identifier: NCT00006994 - Active, not recruiting
  lip and oral cavity cancer; oral complications of chemotherapy and head and neck radiation; Oropharyngeal Cancer; Pain; radiation toxicity
  
• Glutamine in Treating Neuropathy Caused by Vincristine in Young Patients With Lymphoma, Leukemia, or Solid Tumors
  ClinicalTrials.gov Identifier: NCT00365768 - Recruiting
  Kidney Cancer; Leukemia; Lymphoma; Neurotoxicity; Sarcoma
  
• Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation
  ClinicalTrials.gov Identifier: NCT00003898 - Active, not recruiting
  oral complications of cancer and cancer therapy; unspecified childhood solid tumor, protocol specific
  
• Glutamine Popsicles in Bone Marrow Transplant (BMT)/Hematopoietic Stem Cell Transplant (HSCT) Patients
  ClinicalTrials.gov Identifier: NCT00204958 - Recruiting
  Bone Marrow Transplantation; Hematopoietic Stem Cell Transplantion
  
• Glutamine Supplementation to Prevent Death or Infection in Extremely Premature Infants
  ClinicalTrials.gov Identifier: NCT00005775 - Completed
  Sepsis; Infant, Premature, Diseases
  
• Glutaminergic Agents for Cocaine Abuse - 5
  ClinicalTrials.gov Identifier: NCT00000280 - Completed
  Cocaine-Related Disorders
  
• Gluten-Free Diet in Patients with Gluten Sensitivity and Cerebellar Ataxia
  ClinicalTrials.gov Identifier: NCT00006492 - Completed
  Celiac Disease; Cerebellar Ataxia; Healthy
  
• Glyburide Compared to Insulin in the Management of White''s Classification A2 Gestational Diabetes
  ClinicalTrials.gov Identifier: NCT00160485 - Recruiting
  Gestational Diabetes
  
• Glycemic Control and Complications in Diabetes Mellitus Type 2 (VADT)
  ClinicalTrials.gov Identifier: NCT00032487 - Active, not recruiting
  Type 2 diabetes mellitus
  
• Glycemic Control Of Carvedilol Versus Metoprolol In Type II Diabetic Patients With Hypertension
  ClinicalTrials.gov Identifier: NCT00060918 - Completed
  Non-Insulin-Dependent Diabetes Mellitus; Hypertension
  
• Glycemic Control to Prevent Cardiac Morbidity in Vascular Surgery
  ClinicalTrials.gov Identifier: NCT00328094 - Recruiting
  Peripheral Vascular Disease; Abdominal Aortic Aneurysm
  
• Glycemic Index and CVD: a Crossover Feeding Study
  ClinicalTrials.gov Identifier: NCT00141076 - Completed
  Obesity
  
• Glycemic Index, Body Weight and Health
  ClinicalTrials.gov Identifier: NCT00324090 - Completed
  Overweight; Obesity
  
• Glycemic Load, Weight Loss and Cardiovascular Disease Risk
  ClinicalTrials.gov Identifier: NCT00254215 - Completed
  Overweight; Obesity
  
• Glycemic Optimization Treatment Study
  ClinicalTrials.gov Identifier: NCT00552370 - Completed
  Diabetes Mellitus, Type 2
  
• Glycemic Relapse Prevention: Maintenance Dose Assessment
  ClinicalTrials.gov Identifier: NCT00362193 - Completed
  Type 2 Diabetes
  
• Glycemic Stability of Insulin Aspart Versus Insulin Lispro in Insulin Pump Therapy
  ClinicalTrials.gov Identifier: NCT00428207 - Recruiting
  Type 1 Diabetes Mellitus
  
• Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine
  ClinicalTrials.gov Identifier: NCT00541736 - Recruiting
  Familial Hemiplegic Migraine
  
• Glyceryl-Trinitrate-Induced Headache in Patients With Familial Hemiplegic Migraine Type 1 and 2
  ClinicalTrials.gov Identifier: NCT00257985 - Completed
  Familial Hemiplegic Migraine Type 1 and 2; Healthy Volunteers
  
• Glycine and D-Cycloserine in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00000372 - Completed
  Schizophrenia
  
• Glycine to Treat Psychotic Disorders in Children
  ClinicalTrials.gov Identifier: NCT00005658 - Completed
  Psychotic Disorder; Schizoaffecitve Disorder; Schizophrenia
  
• Glycine Treatment of Prodromal Symptoms
  ClinicalTrials.gov Identifier: NCT00268749 - Completed
  Schizophrenia
  
• Glycine Vs Placebo for the Schizophrenia Prodrome
  ClinicalTrials.gov Identifier: NCT00291226 - Not yet recruiting
  Schizophrenia Prodrome
  
• Glycoprotein and Glycan in Patients With Stage I, Stage II, Stage III, or Stage IV Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes
  ClinicalTrials.gov Identifier: NCT00460356 - Recruiting
  Cervical Cancer
  
• GLYCOSA Study:Effect of PAP Treatment on Glycaemic Control in Patients With Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00509223 - Recruiting
  Diabetes Mellitus Type 2
  
• Glycosphingolipid Inhibition and Spermatogenesis in Man: A Pilot Study (MIG 2)
  ClinicalTrials.gov Identifier: NCT00194649 - Completed
  Contraception
  
• Glycyrrhetinic Acid-Effect on Serum Potassium and Insulin Resistance in Dialysis Patients
  ClinicalTrials.gov Identifier: NCT00384384 - Recruiting
  End Stage Renal Disease
  
• GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer
  ClinicalTrials.gov Identifier: NCT00262808 - Completed
  Colorectal Cancer
  
• GM-CSF and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Cisplatin or Carboplatin
  ClinicalTrials.gov Identifier: NCT00466960 - Recruiting
  Fallopian Tube Cancer; Ovarian Cancer; Peritoneal Cavity Cancer
  
• GM-CSF and Rituximab After Autologous Stem Cell Transplant in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin Lymphoma
  ClinicalTrials.gov Identifier: NCT00521014 - Recruiting
  Lymphoma
  
• GM-CSF and Thalidomide in Treating Patients Undergoing Surgery for High-Risk Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00400517 - Completed
  Prostate Cancer
  
• GM-CSF as Adjuvant Therapy of Melanoma
  ClinicalTrials.gov Identifier: NCT00350597 - Completed
  Malignant Melanoma
  
• GM-CSF Before Surgery in Treating Patients With Localized Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00305669 - Recruiting
  Prostate Cancer
  
• GM-CSF in Patients With Pulmonary Alveolar Proteinosis
  ClinicalTrials.gov Identifier: NCT00030056 - Recruiting
  Pulmonary Alveolar Proteinosis
  
• GM-CSF in Women with Recurrent Ovary Cancer
  ClinicalTrials.gov Identifier: NCT00157573 - Recruiting
  Ovarian Cancer; Primary Peritoneal Cancer; Fallopian Tube Cancer
  
• GM-CSF Mouthwash for Preventing and Treating Mucositis in Patients Who Are Undergoing Radiation Therapy for Head and Neck Cancer
  ClinicalTrials.gov Identifier: NCT00293462 - Recruiting
  Head and Neck Cancer; Oral Complications of Chemotherapy and Head/Neck Radiation; Radiation Toxicity
  
• GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid Malignancies
  ClinicalTrials.gov Identifier: NCT00426205 - Active, not recruiting
  Myelodysplastic Syndrome RAEB-I or RAEB-II; Refractory Acute Myeloid Leukemia; Refractory CML Myeloid Blast Crisis
  
• GM-CSF With or Without Vaccine Therapy After Combination Chemotherapy and Rituximab as First-Line Therapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
  ClinicalTrials.gov Identifier: NCT00324831 - Suspended
  Lymphoma
  
• GM1 Ganglioside Effects on Parkinson's Disease
  ClinicalTrials.gov Identifier: NCT00037830 - Active, not recruiting
  Parkinson Disease
  
• GMB: Study of Truvada (TDF+FTC) or Emtricitabine (FTC) Alone Versus HAART Interruption in HIV-Infected Patients With Resistance
  ClinicalTrials.gov Identifier: NCT00362687 - Recruiting
  HIV Infections
  
• GMZ2-Aluminum Hydroxide Phase I, Tübingen
  ClinicalTrials.gov Identifier: NCT00397449 - Active, not recruiting
  Malaria
  
• GnRH Agonist Administration in the Luteal Phase of ICSI-ET Cycles
  ClinicalTrials.gov Identifier: NCT00516490 - Completed
  Infertility
  
• GnRH Agonist and Antagonists in an Oocyte Donation Program
  ClinicalTrials.gov Identifier: NCT00505817 - Active, not recruiting
  Effect of Two Protocols of Ovarian Stimulation on Oocyte Quality
  
• GnRH Agonist and Intrauterine Insemination
  ClinicalTrials.gov Identifier: NCT00503217 - Recruiting
  Intrauterine Insemination
  
• GnRH Analogue for Ovarian Function Preservation In Hematopoietic Stem Cell Transplant Patients
  ClinicalTrials.gov Identifier: NCT00429494 - Recruiting
  Hematopoietic Stem Cell Transplantation
  
• GnRH Antagonist to Prepare Recipients for Embryo Transfer
  ClinicalTrials.gov Identifier: NCT00460642 - Recruiting
  Infertility
  
• GOAL Life-Style Change Intervention to Prevent Type 2 Diabetes
  ClinicalTrials.gov Identifier: NCT00398060 - Active, not recruiting
  Obesity; Type 2 Diabetes
  
• Goal-Directed Afterload Reduction in Acute Congestive Cardiac Decompensation Study
  ClinicalTrials.gov Identifier: NCT00512759 - Not yet recruiting
  Acute Heart Failure
  
• Goal-Orientated Therapy of Perioperative Disturbance in Hemostasis in Cardiac Surgery
  ClinicalTrials.gov Identifier: NCT00516126 - Recruiting
  Cardiac Surgery; Coronary Artery Bypass Graft; Hemostasis
  
• Goblet Cell Response and Dry Eye Symptoms After PRK and LASIK
  ClinicalTrials.gov Identifier: NCT00411827 - Not yet recruiting
  Keratoconjunctivitis Sicca
  
• Gold Against Pains From Osteoarthrosis in the Knee
  ClinicalTrials.gov Identifier: NCT00378339 - Not yet recruiting
  Arthritis
  
• Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00575393 - Recruiting
  Lung Cancer
  
• Gonadotropin-Releasing Hormone Antagonist on Triggering Day: A Randomized Controlled Study
  ClinicalTrials.gov Identifier: NCT00571870 - Recruiting
  Infertility
  
• Gonyautoxin in the Treatment of Chronic Tension-Type Headache
  ClinicalTrials.gov Identifier: NCT00276952 - Terminated
  Tension-Type Headache
  
• GORE VIABAHN ENDOPROSTHESIS Peripheral Vascular Disease Study
  ClinicalTrials.gov Identifier: NCT00228384 - Recruiting
  Peripheral Vascular Diseases
  
• GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface in the Treatment of SFA Obstructive Disease (VIPER)
  ClinicalTrials.gov Identifier: NCT00541307 - Recruiting
  Peripheral Vascular Diseases
  
• GORE-TEX PROPATEN Vascular Graft Study
  ClinicalTrials.gov Identifier: NCT00205790 - Completed
  Peripheral Vascular Diseases
  
• Gortec Head And Neck Carcinoma
  ClinicalTrials.gov Identifier: NCT00408252 - Recruiting
  Recurrent Disease; Squamous Cell Head and Neck Carcinoma; Palliative Treatment
  
• Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer
  ClinicalTrials.gov Identifier: NCT00429403 - Recruiting
  Breast Cancer
  
• Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00217659 - Completed
  Male Breast Cancer; recurrent breast cancer; stage IV breast cancer
  
• Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00427245 - Recruiting
  Breast Cancer; Menopausal Symptoms; Sexual Dysfunction and Infertility
  
• Goserelin in Preventing Ovarian Failure in Women Receiving Adjuvant Chemotherapy for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00068601 - Recruiting
  Breast Cancer; Hot Flashes; menopausal symptoms; Osteoporosis; sexual dysfunction and infertility
  
• Goserelin Plus Letrozole in Premenopausal Patients Versus Letrozole Alone in Postmenopausal Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00532272 - Recruiting
  Breast Cancer; Metastatic
  
• Gossypol (AT-101) and Temozolomide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00390403 - Recruiting
  Brain and Central Nervous System Tumors
  
• Gossypol in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
  ClinicalTrials.gov Identifier: NCT00540722 - Not yet recruiting
  Brain and Central Nervous System Tumors
  
• Gossypol, Cisplatin, and Etoposide in Treating Patients With Advanced Solid Tumors or Extensive Stage Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00544596 - Recruiting
  Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
  
• gp100 and MART-1 Peptide Vaccine for Metastatic Melanoma
  ClinicalTrials.gov Identifier: NCT00001833 - Completed
  Melanoma; Neoplasm Metastasis
  
• gp100 and MART-1 Peptide Vaccine for Metastatic Ocular Melanoma
  ClinicalTrials.gov Identifier: NCT00009516 - Completed
  Melanoma
  
• gp100 and MDX-010 Vaccination for Stage IV Melanoma
  ClinicalTrials.gov Identifier: NCT00029549 - No longer recruiting
  Melanoma
  
• GP96 Heat Shock Protein-Peptide Complex Vaccine in Treating Patients With Recurrent or Progressive Glioma
  ClinicalTrials.gov Identifier: NCT00293423 - Recruiting
  Brain and Central Nervous System Tumors
  
• GPIAG and Leicester Asthma and Dysfunctional Breathing (GLAD) Study: a Randomised Controlled Study
  ClinicalTrials.gov Identifier: NCT00515840 - Active, not recruiting
  Asthma; Dysfunctional Breathing
  
• GPIIbIIIa Inhibitors in the RESCUe and RESURCOR Networks at the Acute Myocardial Infarction
  ClinicalTrials.gov Identifier: NCT00538317 - Recruiting
  Acute Myocardial Infarction
  
• GPX-100 in Treating Patients With Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003403 - Completed
  unspecified adult solid tumor, protocol specific
  
• GR Defect in Peripheral Blood Mononuclear Cells in COPD
  ClinicalTrials.gov Identifier: NCT00159237 - Recruiting
  Chronic Obstructive Pulmonary Disease
  
• GR Defect in Sputum Cells in COPD
  ClinicalTrials.gov Identifier: NCT00159276 - Not yet recruiting
  Chronic Obstructive Pulmonary Disease (COPD)
  
• GR270773 In The Treatment Of Suspected Or Confirmed Gram-negative Severe Sepsis In Adults
  ClinicalTrials.gov Identifier: NCT00089986 - Completed
  Sepsis; Septic Shock
  
• GRACE: A Study to Compare the Effectiveness, Safety and Tolerability of PREZISTA (Darunavir)/Ritonavir by Gender and Race When Administered With Other Antiretroviral Medications in Human Immunodeficiency Virus (HIV) Positive Women and Men.
  ClinicalTrials.gov Identifier: NCT00381303 - Recruiting
  HIV
  
• GRACE: Geriatric Resources for Assessment and Care of Elders
  ClinicalTrials.gov Identifier: NCT00182962 - Completed
  Functional Decline; Aging
  
• Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis carinii Pneumonia Prophylaxis
  ClinicalTrials.gov Identifier: NCT00000816 - Completed
  Pneumonia, Pneumocystis carinii; HIV Infections
  
• Gradual Vs. Abrupt Cessation Treatment for Smoking
  ClinicalTrials.gov Identifier: NCT00297492 - Recruiting
  Smoking Cessation
  
• Gradual vs. Rapid Buprenorphine Detoxification - 2
  ClinicalTrials.gov Identifier: NCT00000220 - Completed
  Opioid-Related Disorders
  
• Gradual Withdrawal of Immune System Suppressing Drugs in Hepatitis C Virus Patients Receiving a Liver Transplant
  ClinicalTrials.gov Identifier: NCT00135694 - Recruiting
  Hepatitis C; Hepatitis C, Chronic
  
• Graduated Recovery Intervention Program for Enhancing Treatment for First-Episode Psychosis
  ClinicalTrials.gov Identifier: NCT00307216 - Recruiting
  Psychotic Disorders; Schizophrenia
  
• Graft Patency in Beating Heart Vs. Conventional CABG Using Cardiac CT
  ClinicalTrials.gov Identifier: NCT00259493 - Recruiting
  Coronary Artery Disease Amenable to Bypass Graft Surgery
  
• Graft-Augmented Rectocele Repair-A Randomized Surgical Trial
  ClinicalTrials.gov Identifier: NCT00321867 - Recruiting
  Rectocele
  
• Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease
  ClinicalTrials.gov Identifier: NCT00003414 - Active, not recruiting
  Lymphoma
  
• Graft-Versus-Host Disease Prevention in Treating Patients Who Are Undergoing Bone Marrow Transplantation
  ClinicalTrials.gov Identifier: NCT00002456 - Completed
  recurrent adult non-Hodgkin's lymphoma; recurrent childhood acute lymphoblastic leukemia; recurrent adult acute myeloid leukemia; ...
  
• Gram Negative Bacteremia, Risk Factors for Failure of Therapy
  ClinicalTrials.gov Identifier: NCT00177957 - Recruiting
  Gram-Negative Bacterial Infections
  
• Granisetron to Prevent Nausea and Vomiting After Chemotherapy in Patients With Malignant Disease
  ClinicalTrials.gov Identifier: NCT00005024 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Granisetron, Dexamethasone, Prochlorperazine, Aprepitant, and Palonosetron in Preventing Nausea in Women Undergoing Chemotherapy for Breast Cancer
  ClinicalTrials.gov Identifier: NCT00475085 - Recruiting
  Breast Cancer; Nausea and Vomiting
  
• Granulocyte Colony Stimulating Factor (G-CSF) for Bone Marrow Transplant (BMT)
  ClinicalTrials.gov Identifier: NCT00231309 - Recruiting
  Hematologic Diseases; Hematologic Malignancies
  
• Granulocyte Transfusion Study
  ClinicalTrials.gov Identifier: NCT00000581 - Completed
  Blood Transfusion; Infection
  
• Granulocyte-Macrophage Colony Stimulating Factor to Decrease Mechanical Ventilation in Patients With Acute Lung Injury/Acute Respiratory Distress Syndrome
  ClinicalTrials.gov Identifier: NCT00201409 - Recruiting
  Respiratory Distress Syndrome, Adult
  
• Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Maintenance of Prostate Cancer for Patients Responding to Taxotere
  ClinicalTrials.gov Identifier: NCT00274287 - Recruiting
  Prostate Cancer
  
• Granulocyte-Macrophage Colony-Stimulating Factor and Zidovudine: A Phase I Study of Concurrent Administration in Patients With AIDS and Severe ARC
  ClinicalTrials.gov Identifier: NCT00000711 - Completed
  HIV Infections; Cytopenias
  
• Grass Pollen Immunotherapy Using a Cluster Regime for Seasonal Rhinitis and Asthma
  ClinicalTrials.gov Identifier: NCT00135642 - Completed
  Seasonal Allergic Rhinoconjunctivitis
  
• Green Laser Photocoagulation Study in Proliferative Diabetic Retinopathy
  ClinicalTrials.gov Identifier: NCT00355680 - Completed
  Diabetic Retinopathy
  
• Green Tea and Ultraviolet Light-Induced Skin Damage
  ClinicalTrials.gov Identifier: NCT00134381 - Recruiting
  Normal volunteer study
  
• Green Tea Consumption and Coronary Heart Disease
  ClinicalTrials.gov Identifier: NCT00005548 - Completed
  Cardiovascular Diseases; Coronary Disease; Heart Diseases
  
• Green Tea Extract (Polyphenon E) in Preventing Cancer in Healthy Participants
  ClinicalTrials.gov Identifier: NCT00091325 - Completed
  unspecified adult solid tumor, protocol specific
  
• Green Tea Extract (Polyphenon® E) and Low-Dose Aspirin in Preventing Cancer in Women at High Risk For Developing Breast Cancer
  ClinicalTrials.gov Identifier: NCT00074061 - No longer recruiting
  Breast Cancer
  
• Green Tea Extract in Preventing Cancer in Former and Current Heavy Smokers With Abnormal Sputum
  ClinicalTrials.gov Identifier: NCT00573885 - Suspended
  Lung Cancer; Tobacco Use Disorder
  
• Green Tea Extract in Preventing Cervical Cancer in Patients With Human Papillomavirus and Low-Grade Cervical Intraepithelial Neoplasia
  ClinicalTrials.gov Identifier: NCT00303823 - Recruiting
  Cervical Cancer; Precancerous/Nonmalignant Condition
  
• Green Tea Extract in Preventing Esophageal Cancer in Patients With Barrett''s Esophagus
  ClinicalTrials.gov Identifier: NCT00233935 - Recruiting
  Esophageal Cancer; Precancerous Condition
  
• Green Tea Extract in Treating Patients With Actinic Keratosis
  ClinicalTrials.gov Identifier: NCT00005097 - Active, not recruiting
  actinic keratosis; squamous cell carcinoma of the skin; prevention of skin cancer; basal cell carcinoma of the skin
  
• Green Tea Extract in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00003197 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
  ClinicalTrials.gov Identifier: NCT00005828 - Completed
  stage IV prostate cancer; recurrent prostate cancer
  
• Green Tea Extract in Treating Patients With Prostate Cancer Undergoing Surgery to Remove the Prostate
  ClinicalTrials.gov Identifier: NCT00459407 - Recruiting
  Prostate Cancer
  
• Green Tea Extract in Treating Patients With Stage 0, Stage I, or Stage II Chronic Lymphocytic Leukemia
  ClinicalTrials.gov Identifier: NCT00262743 - Recruiting
  Leukemia
  
• Green Tea Extract in Treating Women With Hormone Receptor-Negative Stage I, Stage II, or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00516243 - Recruiting
  Breast Cancer
  
• Green Tea or Polyphenon E in Preventing Lung Cancer in Former Smokers With Chronic Obstructive Pulmonary Disease
  ClinicalTrials.gov Identifier: NCT00363805 - Recruiting
  Lung Cancer; Pulmonary Complications
  
• Greenwich Lumbar Stenosis SLIP Study
  ClinicalTrials.gov Identifier: NCT00109213 - Recruiting
  Spinal Stenosis; Spondylolisthesis
  
• GRIB Forsoeget-2004
  ClinicalTrials.gov Identifier: NCT00554645 - Completed
  Overweight
  
• Group Based Exposure Therapy for Combat-Related PTSD
  ClinicalTrials.gov Identifier: NCT00535223 - Not yet recruiting
  Posttraumatic Stress Disorder
  
• Group Cognitive Behavioral Therapy (CBT I) Vs. Quetiapine for Residual Insomnia Impairing Recovery Among Elderly With Stable Major Affective Disorders
  ClinicalTrials.gov Identifier: NCT00462618 - Recruiting
  Insomnia
  
• Group Cognitive Behavioral Therapy to Treat Depression in an Epilepsy Clinic Setting
  ClinicalTrials.gov Identifier: NCT00285740 - Active, not recruiting
  Epilepsy; Depressive Disorder
  
• Group Counseling for Smoking Cessation
  ClinicalTrials.gov Identifier: NCT00104481 - Active, not recruiting
  Smoking
  
• Group Empowerment of Battered Women as a Tool for Violence Prevention
  ClinicalTrials.gov Identifier: NCT00453466 - Completed
  Domestic Violence
  
• Group Interpersonal Psychotherapy for Depressed Adolescents in School-Based Clinics
  ClinicalTrials.gov Identifier: NCT00270244 - Recruiting
  Depression
  
• Group Prenatal Care for Reducing the Risk of STDs in Pregnant Young Women
  ClinicalTrials.gov Identifier: NCT00271960 - Active, not recruiting
  Sexually Transmitted Diseases; HIV Infections
  
• Group Program to Help With Diabetes Management
  ClinicalTrials.gov Identifier: NCT00554671 - Not yet recruiting
  Diabetes Mellitus; Cardiovascular Diseases; Guideline Adherence
  
• Group Psychoeducational Treatment for Women with Sexual Arousal Difficulties
  ClinicalTrials.gov Identifier: NCT00175539 - Recruiting
  Sexual Dysfunctions, Psychological
  
• Group Psychotherapy for People With HIV
  ClinicalTrials.gov Identifier: NCT00186550 - Completed
  HIV; Depression; Risk-Taking; Pain
  
• Group Therapies for Reducing HIV-Risk Behavior in Women Who Have Survived Childhood Sexual Abuse
  ClinicalTrials.gov Identifier: NCT00220597 - Completed
  Alcoholism; Child Abuse, Sexual; Sexual Abuse; Sexual Behavior; Sexually Transmitted Diseases, Viral
  
• Group Therapy Compared With Educational Materials in Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00002848 - Active, not recruiting
  stage I prostate cancer; stage II prostate cancer; psychosocial effects/treatment; Quality of Life
  
• Group Therapy for Nicotine Dependence
  ClinicalTrials.gov Identifier: NCT00297479 - Recruiting
  Smoking; Tobacco Use Cessation
  
• Group Therapy for Postpartum Depression
  ClinicalTrials.gov Identifier: NCT00051246 - Active, not recruiting
  Depression, Postpartum
  
• Group Therapy for Primary Breast Cancer
  ClinicalTrials.gov Identifier: NCT00220792 - Completed
  Breast Cancer
  
• Group Therapy for Women Recovering From Alcohol and Drug Abuse - 1
  ClinicalTrials.gov Identifier: NCT00230100 - Active, not recruiting
  Alcohol-Related Disorders; Behavior Therapy; Substance-Related Disorders
  
• Group Visits to Improve Hypertension Management
  ClinicalTrials.gov Identifier: NCT00129493 - Completed
  Hypertension
  
• Group-Based Contingency Management for Substance Abuse Treatment - 1
  ClinicalTrials.gov Identifier: NCT00249717 - Recruiting
  Contingency Management
  
• Growing Future Physician Leaders: A Randomized Trial of an Educational Intervention in Postgraduate Trainees
  ClinicalTrials.gov Identifier: NCT00286975 - Completed
  Leadership Skills and Knowledge in Postgraduate Trainees
  
• Growth and Development Study of Myozyme
  ClinicalTrials.gov Identifier: NCT00486889 - Not yet recruiting
  Pompe Disease; Glycogen Storage Disease Type II (GSD-II); Acid Maltase Deficiency Disease
  
• Growth and Metabolic Response to Growth Hormone and Gonadotropin-Releasing Hormone Agonist Treatment Versus Growth Hormone Alone in Boys Born SGA.
  ClinicalTrials.gov Identifier: NCT00522743 - Active, not recruiting
  SGA and Growth
  
• Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer
  ClinicalTrials.gov Identifier: NCT00004132 - Completed
  Leukemia; Lymphoma; Multiple Myeloma
  
• Growth Hormone Administration and Its Effects on Cardiovascular Risk Factors in Growth Hormone Deficient Women
  ClinicalTrials.gov Identifier: NCT00136032 - Active, not recruiting
  Growth Hormone Deficiency; Pituitary Tumor; Pituitary Disease
  
• Growth Hormone and Chromosome 18q- Abnormal Growth
  ClinicalTrials.gov Identifier: NCT00134420 - Active, not recruiting
  Chromosome 18; Growth Hormone Deficiency
  
• Growth Hormone and Endothelial Function in Children
  ClinicalTrials.gov Identifier: NCT00373386 - Active, not recruiting
  Growth Hormone Deficiency; Panhypopituitarism; Short Stature
  
• Growth Hormone and GnRH Agonist in Adolescents With Acquired Hypothyroidism
  ClinicalTrials.gov Identifier: NCT00206375 - Recruiting
  Hypothyroidism
  
• Growth Hormone and Heart Failure
  ClinicalTrials.gov Identifier: NCT00190359 - Terminated
  Heart Failure, Congestive
  
• Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance
  ClinicalTrials.gov Identifier: NCT00130286 - Recruiting
  HIV-Associated Lipodystrophy Syndrome; Insulin Resistance; Visceral fat accumulation; Fat accumulation; HIV-Associated Metabolic Syndrome
  
• Growth Hormone as a Determinant of Weight Regulation.
  ClinicalTrials.gov Identifier: NCT00355784 - Recruiting
  Obesity
  
• Growth Hormone as Add-on Treatment in Severe Fibromyalgia With Low IGF-1 Serum Levels (56 Characters)
  ClinicalTrials.gov Identifier: NCT00497562 - Completed
  Fibromyalgia; Growth Hormone Deficiency
  
• Growth Hormone Deficiency in Adults (GHDA)
  ClinicalTrials.gov Identifier: NCT00519558 - Completed
  Growht Hormone Deficiency, Adults
  
• Growth Hormone Deficiency in Chronic Heart Failure: an Observational Study
  ClinicalTrials.gov Identifier: NCT00511927 - Recruiting
  Ischemic Heart Disease; Dilative Cardiomyopathy; Heart Failure; Growth Hormone Deficiency
  
• Growth Hormone During Fasting.Signaltransduktion in Muscle and Adipose Tissue and Changes in Intrahepatic Lipid Content
  ClinicalTrials.gov Identifier: NCT00476879 - Recruiting
  Metabolism; Fatty Liver
  
• Growth Hormone in Children With Juvenile Rheumatoid Arthritis (JRA) and With Crohn's Disease
  ClinicalTrials.gov Identifier: NCT00511329 - Recruiting
  Arthritis, Juvenile Rheumatoid; Crohn Disease
  
• Growth Hormone in the Treatment of HIV-Associated Wasting
  ClinicalTrials.gov Identifier: NCT00013988 - Completed
  HIV Infections; HIV Wasting Syndrome
  
• Growth Hormone in the Treatment of HIV-Associated Wasting
  ClinicalTrials.gov Identifier: NCT00489528 - Completed
  HIV Infections; HIV Wasting Syndrome
  
• Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances
  ClinicalTrials.gov Identifier: NCT00000380 - Completed
  Sleep Disorders
  
• Growth Hormone Secretagogue MK-677 Therapy Effect on IGF-1 Levels in CKD and ESRD Patients
  ClinicalTrials.gov Identifier: NCT00395291 - Recruiting
  Chronic Kidney Disease; End Stage Renal Disease
  
• Growth Hormone Signaling in Vivo in Humans
  ClinicalTrials.gov Identifier: NCT00512473 - Completed
  Intracellular Signaling Peptides and Proteins
  
• Growth Hormone Therapy in Osteogenesis Imperfecta
  ClinicalTrials.gov Identifier: NCT00001305 - Recruiting
  Dwarfism; Osteogenesis Imperfecta
  
• Growth Hormone to Increase Immune Function in People with HIV
  ClinicalTrials.gov Identifier: NCT00071240 - Active, not recruiting
  HIV Infections
  
• Growth Hormone Treatment in Adult Patients With Chronic Kidney Disease
  ClinicalTrials.gov Identifier: NCT00184652 - Completed
  ESRD
  
• Growth Hormone Treatment in Children Born Small for Gestational Age
  ClinicalTrials.gov Identifier: NCT00184704 - Completed
  Fetal Growth Retardation
  
• Growth Hormone Treatment in Children Born Small for Gestational Age: Assessment of Satisfaction
  ClinicalTrials.gov Identifier: NCT00519844 - Completed
  Small for Gestational Age (SGA)
  
• Growth Hormone Treatment in Infants Aged 1 to 2 Years With Chronic Renal Insufficiency (CRI) and Growth Retardation.
  ClinicalTrials.gov Identifier: NCT00184769 - Completed
  Chronic Renal Insufficiency
  
• Growth Hormone Treatment in Short Children Born Small for Gestational Age
  ClinicalTrials.gov Identifier: NCT00191529 - Completed
  Infant, Small for Gestational Age
  
• Growth Hormone Treatment of Children Born With Retarded Intrauterine Growth at Age 2-5 Years
  ClinicalTrials.gov Identifier: NCT00184691 - Completed
  Fetal Growth Retardation
  
• Growth Hormone Treatment of Children with HIV-Associated Growth Failure
  ClinicalTrials.gov Identifier: NCT00006143 - Active, not recruiting
  HIV Infections
  
• Growth Hormone Treatment of Women With Turner Syndrome.
  ClinicalTrials.gov Identifier: NCT00420654 - Recruiting
  Turner Syndrome
  
• Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
  ClinicalTrials.gov Identifier: NCT00187993 - Recruiting
  Growth Hormone Deficiency
  
• Growth Hormone Treatment Study in Children With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00256555 - Active, not recruiting
  Cystic Fibrosis
  
• Growth Hormone Use in Adolescents and Adults With Cystic Fibrosis
  ClinicalTrials.gov Identifier: NCT00287430 - Active, not recruiting
  Cystic Fibrosis
  
• Growth Hormone Use in Adults With Prader-Willi Syndrome
  ClinicalTrials.gov Identifier: NCT00444964 - Recruiting
  Prader-Willi Syndrome
  
• Growth Hormone Use in Cystic Fibrosis - a Multicenter Study
  ClinicalTrials.gov Identifier: NCT00005112 - Completed
  Cystic Fibrosis
  
• Growth Hormone's Effect on Endothelial Progenitor Cells
  ClinicalTrials.gov Identifier: NCT00397592 - Completed
  Cardiovascular Disease
  
• Growth Hormone's Effect on the Cardiovascular System
  ClinicalTrials.gov Identifier: NCT00397319 - Terminated
  Growth Hormone Deficiency
  
• Growth Hormone, Cardiovascular Risk, and Visceral Adiposity in Women
  ClinicalTrials.gov Identifier: NCT00131378 - Recruiting
  Obesity
  
• Growth in Children With HLHS
  ClinicalTrials.gov Identifier: NCT00277992 - Terminated
  Congenital Disorders
  
• Growth of Airways and Lung Tissues in Premature and Healthy Infants
  ClinicalTrials.gov Identifier: NCT00419588 - Recruiting
  Infant, Premature; Bronchopulmonary Dysplasia; Asthma
  
• Growth Response in Short Children Suffering From a Disease With Growth Retardation and Treated With Somatropin
  ClinicalTrials.gov Identifier: NCT00488124 - Recruiting
  Short Stature
  
• Growth Retardation In Children With Special Pathological Conditions Or Disease
  ClinicalTrials.gov Identifier: NCT00163215 - Recruiting
  GROWTH RETARDATION
  
• GSK1014802 Single Dose Escalation And Their Effect On Resting Motor Threshold In Healthy Volunteers
  ClinicalTrials.gov Identifier: NCT00488566 - Recruiting
  Bipolar Disorder
  
• GSK1349572 First Time in Human Study
  ClinicalTrials.gov Identifier: NCT00555035 - Recruiting
  Healthy Volunteers
  
• GSK1572932A Antigen-Specific Cancer Immunotherapeutic as Adjuvant Therapy in Patients With Non-Small Cell Lung Cancer
  ClinicalTrials.gov Identifier: NCT00480025 - Recruiting
  Tumor Antigen-Positive Non-Small Cell Lung Cancer
  
• GSK159802 In Healthy Male Subjects And Asthmatics
  ClinicalTrials.gov Identifier: NCT00364273 - Completed
  Asthma; Chronic Obstructive Pulmonary Disease
  
• GSK189075, GW869682 Or Placebo In Type 2 Diabetic Patients
  ClinicalTrials.gov Identifier: NCT00291356 - Completed
  Non-Insulin-Dependent Diabetes Mellitus
  
• GSK372475 Bioequivalence Study
  ClinicalTrials.gov Identifier: NCT00488098 - Completed
  Healthy
  
• GSK706769 A First Time in Human Study For Males and Females
  ClinicalTrials.gov Identifier: NCT00539201 - Recruiting
  Healthy Volunteers
  
• GT267-004 versus Vancomycin and GT267-004 versus Metronidazole in Patients with C. difficile-Associated Diarrhea
  ClinicalTrials.gov Identifier: NCT00106509 - Completed
  Clostridium Enterocolitis; Pseudomembranous Colitis
  
• GTA-Glyceryltriacetate for Canavan Disease
  ClinicalTrials.gov Identifier: NCT00278707 - Active, not recruiting
  Infantile Canavan Disease; Deficiency Disease, Aspartoacylase
  
• GTI-2040 and Capecitabine in Treating Patients With Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00068588 - Active, not recruiting
  stage IV breast cancer; recurrent breast cancer; Male Breast Cancer
  
• GTI-2040 and Docetaxel in Treating Patients With Recurrent, Metastatic, or Unresectable Locally Advanced Non-Small Cell Lung Cancer, Prostate Cancer, or Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00074022 - Completed
  adult solid tumor; Non-small cell lung cancer; Prostate Cancer
  
• GTI-2040 and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid Tumors
  ClinicalTrials.gov Identifier: NCT00078962 - Completed
  unspecified adult solid tumor, protocol specific
  
• GTI-2040 and High-Dose Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia
  ClinicalTrials.gov Identifier: NCT00070551 - Active, not recruiting
  recurrent adult acute myeloid leukemia; adult acute myeloid leukemia with t(8;21)(q22;q22); adult acute myeloid leukemia with t(16;16)(p13;q22); ...
  
• GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous Leukemia
  ClinicalTrials.gov Identifier: NCT00459212 - Recruiting
  Leukemia; Myelodysplastic Syndromes
  
• GTI-2040, Docetaxel, and Prednisone in Treating Patients With Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00087165 - Completed
  adenocarcinoma of the prostate; recurrent prostate cancer
  
• GTI-2040, Oxaliplatin, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer or Other Solid Tumors
  ClinicalTrials.gov Identifier: NCT00084643 - Active, not recruiting
  adult solid tumor; Colon Cancer; Rectal Cancer
  
• GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer’s Disease
  ClinicalTrials.gov Identifier: NCT00414622 - Completed
  Alzheimer Disease
  
• Guanfacine Adjunctive Treatment to Atypical Antipsychotics for Cognitive Dysfunction in Schizophrenia
  ClinicalTrials.gov Identifier: NCT00469664 - Recruiting
  Schizophrenia; Schizoaffective Disorder; Cognitive Impairment
  
• Guanfacine for Improving Cognitive Symptoms in People With Schizotypal Personality Disorder
  ClinicalTrials.gov Identifier: NCT00353379 - Recruiting
  Schizotypal Personality Disorder; Personality Disorders
  
• Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD)
  ClinicalTrials.gov Identifier: NCT00018603 - Completed
  Post-Traumatic Stress Disorder
  
• Guanfacine to Treat Borderline Personality Disorder
  ClinicalTrials.gov Identifier: NCT00358969 - Recruiting
  Borderline Personality Disorder
  
• Gubbio Study Five-year Follow-up: Lithium Countertransport, Blood Pressure, and Other Variables
  ClinicalTrials.gov Identifier: NCT00005232 - Completed
  Cardiovascular Diseases; Heart Diseases; Hypertension; Coronary Disease
  
• Guidant Microwave Ablation System for the Treatment of Atrial Fibrillation
  ClinicalTrials.gov Identifier: NCT00111488 - Terminated
  Atrial Fibrillation
  
• Guided Care: Integrating High Tech and High Touch
  ClinicalTrials.gov Identifier: NCT00121940 - Active, not recruiting
  Chronic Disease
  
• Guided Self-Help Treatment for Binge Eating Disorder
  ClinicalTrials.gov Identifier: NCT00158340 - Active, not recruiting
  Eating Disorders; Hyperphagia; Bulimia
  
• Guideline Adherence for Heart Health (GLAD Heart)
  ClinicalTrials.gov Identifier: NCT00224848 - Active, not recruiting
  Cardiovascular Diseases; Hypercholesterolemia; Hypertension
  
• Guidelines Based Undertaking for Improvement in Dyslipidemia Related Events (GUIDE )
  ClinicalTrials.gov Identifier: NCT00408057 - Active, not recruiting
  Cardiovascular Diseases
  
• Guidelines for Acute Sinusitis
  ClinicalTrials.gov Identifier: NCT00132275 - Recruiting
  Acute bacterial sinusitis
  
• Guidelines for Drug Therapy of Hypertension: Closing the Loop
  ClinicalTrials.gov Identifier: NCT00012636 - Completed
  Hypertension
  
• Guidelines for Drug Therapy of Hypertension: Multi-Site Implementation
  ClinicalTrials.gov Identifier: NCT00122161 - Completed
  Hypertension
  
• Guiding Dose Increases in Patients Incompletely Responsive to Usual Doses of Atomoxetine
  ClinicalTrials.gov Identifier: NCT00485407 - Completed
  Attention Deficit Hyperactivity Disorder
  
• Gulf Evaluation of VAlproate (Depakine Chrono) in maNia Study
  ClinicalTrials.gov Identifier: NCT00477373 - Recruiting
  Bipolar Disorder
  
• Gulf, Lantus, Apidra Evaluation in Type 1 Diabetics Study
  ClinicalTrials.gov Identifier: NCT00539448 - Recruiting
  Diabetes Mellitus, Type 1
  
• Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome
  ClinicalTrials.gov Identifier: NCT00551343 - Recruiting
  Prader-Willi Syndrome
  
• GV 1001 Immunotherapy in Patients With Non-Small Cell Lung Cancer (NSCLC)
  ClinicalTrials.gov Identifier: NCT00509457 - Recruiting
  Carcinoma, Non-Small-Cell Lung
  
• GV1001 and Gemcitabine in Sequential Combination to Gemcitabine Monotherapy in Pancreatic Cancer.
  ClinicalTrials.gov Identifier: NCT00358566 - Recruiting
  Adenocarcinoma
  
• GVAX in Advanced Prostate Cancer Patients Made Lymphopenic
  ClinicalTrials.gov Identifier: NCT00122005 - Recruiting
  Prostate Cancer
  
• GVAX® Prostate Cancer Vaccine vs Docetaxel and Prednisone in Patients with Metastatic Hormone-Refractory Prostate Cancer
  ClinicalTrials.gov Identifier: NCT00089856 - Active, not recruiting
  Prostate Cancer
  
• GVH 022P: Study Using Anti Tumor Necrosis Factor Antibody (Infliximab) for Treatment of Acute Graft Versus Host Disease
  ClinicalTrials.gov Identifier: NCT00228839 - Completed
  Graft Vs Host Disease
  
• GVH 0313: Hematopoietic Cell Transplantation for Pediatric Patients With Hematologic Malignancies at High Risk for Transplant Related Mortality With Standard Transplantation
  ClinicalTrials.gov Identifier: NCT00228826 - Recruiting
  Graft Vs Host Disease
  
• GW273225 Therapy Added To Current Seizure Treatments In Patients With Partial Seizures
  ClinicalTrials.gov Identifier: NCT00567424 - Terminated
  Epilepsy
  
• GW406381 In Patients With Peripheral Nerve Injury
  ClinicalTrials.gov Identifier: NCT00279032 - Completed
  Hyperalgesia; Neurodynia; Pain; Trauma
  
• GW572016 and Trastuzumab in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2/neu
  ClinicalTrials.gov Identifier: NCT00085020 - Active, not recruiting
  stage IV breast cancer; Male Breast Cancer; recurrent breast cancer
  
• GW572016 Combined With Trastuzumab For The Treatment Of Previously Trastuzumab-Treated Breast Cancer
  ClinicalTrials.gov Identifier: NCT00371488 - Recruiting
  Breast Cancer
  
• GW572016 For Treatment Of Refractory Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00062686 - Active, not recruiting
  Metastatic breast cancer
  
• GW572016 In Patients With Advanced Or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00462956 - Completed
  Metastatic Breast Cancer Patients Who Have Progressed on Previous Treatments Containing Anthracylines and Taxanes
  
• GW572016 In Patients With ErbB2 Over - Expressing Advanced Or Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00320411 - Active, not recruiting
  Metastatic Breast Cancer
  
• GW572016 With Docetaxel and Trastuzumab for the Treatment Of Untreated ErbB2 Over-Expressing Metastatic Breast Cancer
  ClinicalTrials.gov Identifier: NCT00251433 - Recruiting
  Metastatic Breast Cancer
  
• GW572016, An Oral Drug For Colorectal Cancer Patients Having Prior Therapy With 5-FU Plus CPT-11 And/Or Oxaliplatin
  ClinicalTrials.gov Identifier: NCT00044343 - Active, not recruiting
  Metastatic Colorectal Cancer
  
• GW572016, An Oral Drug For Women With Refractory Metastatic Breast Cancer After First-line Or Second-line Herceptin
  ClinicalTrials.gov Identifier: NCT00044330 - Completed
  Metastatic breast cancer
  
• GW640385 Plus Ritonavir And NRTIs For 48 Weeks In HIV-1 Infected Adults
  ClinicalTrials.gov Identifier: NCT00257621 - Completed
  HIV Infections
  
• GW679769 In Fibromyalgia
  ClinicalTrials.gov Identifier: NCT00264628 - Completed
  Fibromyalgia; Depression
  
• GW786034 (Pazopanib) In Metastatic Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00334282 - Active, not recruiting
  Renal Cell Carcinoma
  
• GW786034 In Patients With Relapsed Or Refractory Soft Tissue Sarcoma
  ClinicalTrials.gov Identifier: NCT00297258 - Active, not recruiting
  Sarcoma; Leiomyosarcoma; Adipocytic Tumors; Synovial Sarcoma
  
• GW786034 In Subjects With Locally Recurrent Or Metastatic Clear Cell Renal Cell Carcinoma
  ClinicalTrials.gov Identifier: NCT00244764 - Active, not recruiting
  Renal Cell Carcinoma; Solid Tumors
  
• GW786034 in Treating Patients With Advanced Solid Tumors
  ClinicalTrials.gov Identifier: NCT00060151 - Active, not recruiting
  unspecified adult solid tumor, protocol specific
  
• GW815SF For Chronic Obstructive Pulmonary Disease (Chronic Bronchitis, Emphysema)
  ClinicalTrials.gov Identifier: NCT00269087 - Completed
  Chronic Obstructive Pulmonary Disease
  
• GW823093C For The Treatment Of Type 2 Diabetes Mellitus
  ClinicalTrials.gov Identifier: NCT00370942 - Suspended
  Diabetes Mellitus, Non-Insulin-Dependent
  
• GW873140 In Combination With Combivir In HIV Infected Subjects
  ClinicalTrials.gov Identifier: NCT00104429 - Terminated
  HIV Infections
  
• GW873140 In Combination With Kaletra In HIV Infected Subjects
  ClinicalTrials.gov Identifier: NCT00102778 - Terminated
  HIV Infections
  
• GW873140 to Treat HIV-1 Infected Adults
  ClinicalTrials.gov Identifier: NCT00076284 - Completed
  
  
• GYNECARE PROSIMA* Pelvic Floor Repair System for Pelvic Organ Prolapse
  ClinicalTrials.gov Identifier: NCT00521066 - Recruiting
  Pelvic Organ Prolapse
  
• Gyrate Atrophy of the Choroid and Retina
  ClinicalTrials.gov Identifier: NCT00001166 - Completed
  Gyrate Atrophy